[
    {
        "pmid": "40813129",
        "title": "Cardiovascular, kidney related, and weight loss effects of therapeutics for type 2 diabetes: a living clinical practice guideline.",
        "abstract": "benefit harm medication adult type 2 diabetes varied risk cardiovascular kidney related complications Emerging clinical trial novel medication demonstrated benefit cardiovascular kidney weight related outcome people type 2 diabetes Dynamically updated practice guideline adhering standard trustworthiness necessary response rapidly evolving evidence base availability multiple medication alternatives living practice guideline incorporates latest available medication evidence provides recommendation stratified risk cardiovascular kidney complication inform diabetes management panel issued riskstratified recommendation regarding four prioritised medication adult type 2 diabetes SGLT2 inhibitors GLP1 receptor agonists finerenone tirzepatide• Lower risk three fewer cardiovascular risk factor without established cardiovascular disease CVD chronic kidney disease CKD weak recommendation SGLT2 inhibitor GLP1 receptor agonists• Moderate risk more three cardiovascular risk factor without established CVD CKD established CVD andor CKD lower risk complications weak recommendation favour SGLT2 inhibitor GLP1 receptor agonists weak recommendation finerenone adult CKD• Higher risk established CVD andor CKD higher risk complications established heart failure strong recommendation favour SGLT2 inhibitor GLP1 receptor agonists weak recommendation favour finerenone adult CKD• Across risk strata weak recommendation favour tirzepatide adult obesity international panel including two patient partners clinicians methodologists produced recommendations panel followed standard trustworthy guideline used GRADE approach explicitly considering balance benefits harm burden treatment individual patient perspective Recommendations informed linked living systematic review network metaanalysis evaluating relative benefit harm updated 31 July 2024 linked systematic review addressing risk prediction model value preference adult type 2 diabetes Candidate therapeutic prioritised based availability sufficient randomised trial data relevance global audience likelihood changing practiceThis first version living guideline guideline part iBMJ Rapid Recommendationsi series MAGICapp display recent version guideline full content including evidence summary decision aids major update published iThe BMJi encourage reuse adaptation translation living guidelines recognise lack availability high cost medication may prohibitive impact recommendation implemented across different health care systems",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40813129/",
        "source_type": "Global"
    },
    {
        "pmid": "40810311",
        "title": "Identifying essential COVID-19 indicators for primary healthcare through Delphi analysis in 31 European countries: Eurodata eDelphi study.",
        "abstract": "COVID19 pandemic underlined essential role primary healthcare PHC epidemiological surveillance public health decisionmaking Across Europe integration electronic health record EHRs sentinel network pivotal monitoring COVID19 However lack standardized PHC indicator COVID19 hinders comparability data among countries establish consensus set standardized PHC activity indicator related COVID19 pandemic 31 countries enhancing capability health authority make informed decision prepare future health crises tworound eDelphi study conducted using structured webbased survey following CREDES guidelines achieve consensus among panel 164 expert Eurodata study 86 Indicators selected based availability current pandemic participant rating relevance utility proposed indicators 22 initial indicators seven received consensus inclusion two remained contentious second round study found significant discrepancy awareness sentinel network accessibility PHC data consensus emphasized necessity indicator standardized reproducible easily extractable databases recommendation disaggregation age sex vaccination status Key COVID19 indicator PHC identified reflecting consensus among healthcare professionals cooperation PHC provider national public health authority warranted national international level harmonized healthcare indicator response future health emergencies",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40810311/",
        "source_type": "Global"
    },
    {
        "pmid": "40809422",
        "title": "Environmental cadmium exposure and the risk of kidney stones: a systematic review and dose-response meta-analysis.",
        "abstract": "Recent study investigated relationship cadmium exposure kidney stones Nevertheless result remain controversial Therefore performed comprehensive systematic review metaanalysis based latest evidence address gap research Medline Embase Web Science database searched identify relevant study 31 July 2024 Characteristics outcome included study extracted following Preferred Reporting Items Systematic Reviews MetaAnalyses PRISMA guideline Metaanalyses Observational Studies Epidemiology MOOSE guidelines random effect model used determine association cadmium exposure risk kidney stones total 17 study involving 159011 individual included metaanalysis comparing highest versus lowest cadmium exposure levels overall relative risk RR kidney stone 119 95 confidence interval CI 110129 Subgroup analysis showed urinary RR  119 95CI 108130 blood RR  149 95 CI 110202 cadmium level associated increased risk kidney stones contrast noncadmiumcontaminated areas blood RR  108 95 CI 100115 urinary RR  116 95 CI 105127 cadmium level associated increased risk kidney stone cadmiumcontaminated areas doseresponse metaanalysis observed consistent linear positive association cadmium exposure risk kidney stones overall RR every 10 μgL increase urinary cadmium level 107 95 CI 101113 finding suggest cadmium exposure associated risk kidney stones finding reinforce importance environmental cadmium exposure risk factor kidney stones extending beyond influence conventional risk factors Efforts reduce cadmium exposure population may help reduce individual economic societal burden associated kidney stones httpswwwcrdyorkacukPROSPEROmyprospero",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40809422/",
        "source_type": "Global"
    },
    {
        "pmid": "40801954",
        "title": "Meropenem and piperacillin/tazobactam optimised dosing regimens for critically ill patients receiving renal replacement therapy.",
        "abstract": "Optimal dosing meropenem piperacillintazobactam critically ill patient receiving renal replacement therapy RRT uncertain due variable pharmacokinetics aimed develop generalisable optimised dosing recommendation antibiotics Prospective multinational pharmacokinetic study including patient requiring various form RRT Independent population PK model developed externally validated applied perform Monte Carlo dosing simulation using Monolix Simulx calculated probability dosing regimen achieved standard high therapeutic unbound antibiotic concentration 100 dosing interval treatment Enterobacterales Pseudomonas aeruginosa enrolled 300 patient 22 intensive care unit across 12 country receiving continuous venovenous haemodialysis 130 haemofiltration 233 haemodiafiltration 484 sustained lowefficiency dialysis 153 Models developed using data 234 patient 8322 samples validated 66 additional patient 560 samples Predictive performance high mean prediction error  52 meropenem  169 piperacillin Dosing simulation showed meropenem piperacillintazobactam dosing requirement dependent urine output RRT intensity duration p  005 scenarios extendedcontinuous infusion led better achievement effective concentration lower daily dos compared short infusion Dosing nomogram developed inform dosing different RRT settings urine outputs target concentrations RRT intensity duration urine output determine meropenem piperacillintazobactam dosing requirement critically ill patient receiving RRT Extendedcontinuous infusion facilitate attainment effective concentrations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40801954/",
        "source_type": "Global"
    },
    {
        "pmid": "40800225",
        "title": "Identifying stakeholders and analyzing their concerns about African swine fever control in wild boar.",
        "abstract": "African swine fever ASF approaching Switzerland continues spread across Europe viral disease affect porcine species leading severe economic loss reaching domestic pig sector Controlling ASF wild boar population complex requires coordination among diverse stakeholder varying role interests used participatory approach data generation including desk research qualitative interviews focus group discussions workshops applied reflexive thematic analysis systematically identify relevant actor assess concerns guided Mendelow PowerInterest Grid stakeholder mapping Results reveal broad spectrum stakeholders including federal cantonallevel authorities private industry sector nongovernmental organization NGOs private individuals well academic diagnostic institutions Stakeholder mapping underscore central role federal cantonal authority ASF control demonstrates hunting sectors dual position impacted actively involved control efforts Stakeholders concern fall five key areas economic risk material shortages legal framework bureaucratic obstacles challenge communication coordination animal welfare environmental issues Findings emphasize need improved governance clearer guidelines stronger coordination among federal cantonal authorities research demonstrates value participatory approach disease management enhancing collaboration identifying critical gaps strengthening preparedness response efforts example ASF Switzerland",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40800225/",
        "source_type": "Global"
    },
    {
        "pmid": "40796795",
        "title": "Association between placental epigenetic age acceleration and early postnatal growth patterns.",
        "abstract": "Placental gestational age acceleration GAA difference actual gestational age GA birth estimated epigenetic gestational age EGA calculated placental DNA methylation Understanding role placental GAA postnatal growth trajectory crucial early identification infant risk altered growth pattern associated longterm health outcomes objective study investigate association placental GAA longitudinal growth trajectory specifically weight height fat mass lean mass gain early childhood study us placental DNA methylation birth calculate epigenetic GAA longitudinal measure weight height fat mass lean mass generate growth trajectory characteristics Higher placental GAA significantly associated slower weight gain 95 CI  003  0001 fat mass 95 CI  008  002 gain well reduced average fat mass 95 CI add this followup period However significant association found GAA height lean mass gain Placental GAA give early insight altered postnatal growth trajectories particularly weight fat mass increase GAA associated decreased weight fatmass gain time observed effect height lean mass Understanding association offer insight early developmental pattern longterm health outcome children highlighting importance perinatal factor shaping growth trajectory early childhood",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40796795/",
        "source_type": "Global"
    },
    {
        "pmid": "40794908",
        "title": "The world falls guidelines: how is implementation progressing globally?",
        "abstract": "World guideline fall prevention management older adult WFG 2022 represent global initiative address rising incidence fall related injury WFG provides evidencebased recommendation across various settings including community hospital care home environments recent report highlighted large variation implementation progress WFG across Europe However date comprehensive global overview WFG implementation status undertaken address gap reached expert took part WFG inquire implementation status WFG countries response expert 18 country one Africa six Asia one Europe three North America one Oceania six South America revealed effort implement WFG underway many them differing degree progress varying advanced integration guidelinespolicies nominimal actions global implementation status WFG encouraging significant barrier remain including limited resources competing health priorities cultural difference care models Adapting WFG diverse healthcare system integrating fall prevention national policy health priority essential enable effective implementation Furthermore strengthening global collaboration sharing best practices prioritisation effective feasible fall prevention component low resource settings advocating fall prevention public health priority help accelerate progress across world benefit older patient risk falling",
        "mesh_terms": [
            "Aged",
            "Humans",
            "Accidental Falls",
            "Global Health",
            "Practice Guidelines as Topic",
            "Risk Factors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40794908/",
        "source_type": "Global"
    },
    {
        "pmid": "40791927",
        "title": "The Burden of COPD with Type 2 Inflammation in North-West Continental Europe.",
        "abstract": "Chronic obstructive pulmonary disease COPD complex heterogeneous disease place huge burden patients health system societies Yet despite this COPD often neglected frequently underdiagnosed misdiagnosed since tobacco exposure primary risk factor development patient often stigmatized marginalized perceived selfinflicted disease COPD primarily understood functional disorder chronic airway obstruction yet several underlying inflammatory pathways patient COPD type 1 neutrophilic inflammation main pathway however considerable proportion type 2 inflammation associated elevated eosinophil numbers COPD type 2 inflammation may represent distinct COPD phenotype treatable trait fact response inhaled corticosteroid ICS linked blood eosinophil levels treatment effect begin increase patient blood eosinophil count ≥100 cellsμL treatment guideline recommend considering ICS patient blood eosinophil count ≥300 cellsμL Data burden COPD type 2 inflammation limited COPD type 2 inflammation may associate poor outcomes higher blood eosinophil count positively associate increased risk moderate severe exacerbations Exacerbations among dangerous aspect COPD accelerating disease progression increasing morbidity mortality review explores burden COPD  specifically eosinophilic COPD  across northwestern Europe aim provide information relevant patients clinician policymakers educating type 2 inflammation contribution disease burden informed multiple stakeholders including patients offer practical achievable recommendation enhancing care patient COPD better understanding COPD type 2 inflammation",
        "mesh_terms": [
            "Humans",
            "Pulmonary Disease, Chronic Obstructive",
            "Europe",
            "Cost of Illness",
            "Risk Factors",
            "Inflammation",
            "Lung",
            "Phenotype",
            "Disease Progression",
            "Eosinophils",
            "Adrenal Cortex Hormones"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40791927/",
        "source_type": "Global"
    },
    {
        "pmid": "40790161",
        "title": "Cruciferous vegetables intake and risk of colon cancer: a dose-response meta-analysis.",
        "abstract": "Colon cancer CC third diagnosed malignancy second leading cause cancer mortality globally  19 million new case 903859 death annually Bray et al CA Cancer J Clin 686394424 2018 Diet represents key modifiable risk factor CC pathogenesis Herr Buchler Cancer Treat Rev 36377383 2010 Cruciferous vegetable CVrich glucosinolates hydrolyze bioactive isothiocyanate Willett Cancer Epidem Biomar 1038 2001 Murillo Mehta Nutr Cancer 41121728 2001 Higdon et al Pharmacol Res 5522436 2007exhibit chemopreventive property carcinogen detoxification apoptosis induction cell cycle arrest Zhang et al Proc Nutr Soc 656875 2006 prior metaanalyses report inverse association CV intake CC risk Tse Eslick Nutr Cancer 66112839 2014 quantitative doseresponse relationship remains uncharacterized limiting translational insight dietary guidance thorough search literature conducted Embase ScopusWeb Science PubMed Cochrane Library inception June 28 2025 using predetermined strategy encompassing cohort casecontrol studies Two independent reviewer selected study based predefined inclusion criteria discrepancy resolved consensus senior investigator adjudication Statistical analysis performed using Stata version 142 Subgroup analysis accounted study design geographic location potential confounders Publication bias assessed using Eggers test LFK index trimandfill method Sensitivity analysis employed leaveoneout approach doseresponse relationship evaluated using restricted cubic spline models Data 17 researchincluding 7 cohort study 10 casecontrol studieswith 97595 patient methodically combined investigationConsumption CV found inversely correlated CC risk odds ratio OR  08 95 confidence interval CI 072090 pooled analysis using randomeffects model Furthermore progressive decrease risk shown nonlinear doseresponse analysis consumption level increased metaanalysis suggests potential inverse association higher CV intake CC incidence However finding interpreted cautiously due methodological limitations including heterogeneity study designs dietary assessment method potential residual confounding",
        "mesh_terms": [
            "Humans",
            "Colonic Neoplasms",
            "Vegetables",
            "Brassicaceae",
            "Risk Factors",
            "Diet",
            "Isothiocyanates",
            "Glucosinolates"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40790161/",
        "source_type": "Global"
    },
    {
        "pmid": "40789882",
        "title": "Pulse pressure after thrombectomy predicts functional outcomes and mortality in acute ischemic stroke with large artery occlusion.",
        "abstract": "Postprocedure blood pressure BP strongly influence prognosis ischemic stroke patient large vessel occlusion However consensus guideline currently exist regarding BP target management endovascular thrombectomy EVT Although several recent clinical trial investigated BP management EVT conclusion inconsistent contradictory study systematically analyzed 12 postprocedure BP parameter 826 acute ischemic stroke patient within 24 h EVT 587 case included final analysis utilized multivariate logistic regression identify predictor poor prognosis mortality EVT Restrictive cubic spline used evaluate doseresponse relationship mean pulse pressure PP clinical outcomes Subgroup analysis conducted assess predictive performance mean PP across patient subgroups Mean PP demonstrated statistically significant positive doseresponse relationship poor functional outcomes symptomatic intracranial hemorrhage sICH mortality EVT Elevated mean PP  5739 mmHg stronger predictor adverse outcome relative systolic diastolic BP alone exhibited highest adjusted odds ratio aORs 239 95 confidence interval CI 158362 area curve AUC  0661 95 CI 06170705 Mean PP exhibited linear relationship outcome event except mortality 12 month EVT Mean PP within 24 h EVT independent risk factor sICH poor functional outcomes mortality stroke patients BP management strategy prioritize reducing systolic BP stabilizing PP fluctuations",
        "mesh_terms": [
            "Humans",
            "Thrombectomy",
            "Male",
            "Aged",
            "Female",
            "Blood Pressure",
            "Ischemic Stroke",
            "Middle Aged",
            "Prognosis",
            "Treatment Outcome",
            "Aged, 80 and over",
            "Endovascular Procedures",
            "Brain Ischemia"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40789882/",
        "source_type": "Global"
    },
    {
        "pmid": "40787612",
        "title": "Micronutrient and protein-energy supplementation enhance vaccine responses in undernourished children: Evidence from a systematic review.",
        "abstract": "Malnutrition impairs immune function vaccine responses particularly lowincome settings lead reduced seroconversion rate compromised herd immunity children Nutritional intervention proposed enhance vaccine immunogenicity yet evidence remains scattered context specific systematic review assesses impact nutritional interventionsespecially vitamin A zinc supplementation proteinenergy rehabilitationon serological response routine childhood vaccine among malnourished child low middleincome countries Following PRISMA guidelines searched PubMed Embase Cochrane Library Global Health Library study published 2000 2024 Eligible study included randomized trials cohort studies systematic review reporting nutritional supplementation vaccine seroconversion outcome malnourished children 3245 records 42 study met inclusion criteria Vitamin supplementation improved measles vaccine seroconversion 35 especially among deficient children Zinc enhanced response oral vaccine 20 Proteinenergy rehabilitation significantly increased seroconversion rate BCG measles vaccines particularly child recovering severe acute malnutrition Nutritional intervention improve vaccine immunogenicity among malnourished children Integrated strategy combining immunization nutrition service prioritized address immunity gap vulnerable populations",
        "mesh_terms": [
            "Humans",
            "Dietary Supplements",
            "Micronutrients",
            "Child",
            "Vitamin A",
            "Malnutrition",
            "Zinc",
            "Child Nutrition Disorders",
            "Child, Preschool"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40787612/",
        "source_type": "Global"
    },
    {
        "pmid": "40785656",
        "title": "Sepsis management in a rural hospital in Northwest Ontario.",
        "abstract": "retrospective quantitative study emergency department ED management patient diagnosed sepsis rural hospital northwest Ontario conducted understand management sepsis guideline department performance study includes adult ED patient 18 receiving ED diagnosis sepsis identified hospital medical record coding according National Ambulatory Care Reporting System diagnostic code January 1 2021 December 31 2021 Charts reviewed patient demographics initial presentation timing ED management outcomes Statistical analysis involved descriptive methods Twentyfive adult eligible 16 female average age 531 year standard deviation SD  219 Mortality rate 28 average age 7 nonsurvivors 64 SD  1473 Time nursing assessment averaged 8 min SD  727 time MD assessment 41 min SD  3093 Canadian Triage Acuity Scale score urgent higher 20 23 cases Retrospective Systemic inflammatory Response Syndrome score elevated 1725 cases Average time fluid administration 85 min SD  7941 Sixteen 23 patient recorded time antibiotic delivery received 180 min less Patients sepsis present variety clinical features laboratory findings Awareness urgency sepsis treatment organised departmental approach important management potentially septic patients Une étude quantitative rétrospective sur la prise en charge aux urgences de patient diagnostiqués avec une septicémie dans un hôpital rural du nordouest de lOntario été menée afin de comprendre le directive en matière de prise en charge de la septicémie et le performance du service Notre étude porte sur tous le patient adultes âgés de 18 an et plus admis aux urgences et ayant reçu un diagnostic de septicémie selon le codage de dossier médicaux de lhôpital conformément aux code diagnostiques du Système national dinformation sur le soins ambulatoires SNISA entre le 1er janvier 2021 et le 31 décembre 2021 Les dossier ont été examinés afin de recueillir de données démographiques sur le patients le premier symptômes le moment de la prise en charge aux urgences et le résultats Lanalyse statistique été réalisée à laide de méthodes descriptives Vingtcinq adultes étaient admissibles dont 16 femmes avec un âge moyen de 531 an écarttype  219 Le taux de mortalité était de 28 Lâge moyen de seven patient décédés était de 64 an écarttype  1473 Le délai moyen avant lévaluation infirmière était de 8 min écarttype  727 le délai avant lévaluation médicale était de 41 min écarttype  309 Les score de léchelle canadienne de triage et dacuité étaient urgents ou supérieurs dans 20 ca sur 23 Les score rétrospectifs du syndrome de réponse inflammatoire systémique étaient élevés dans 17 ca sur 25 Le délai moyen avant ladministration de liquides était de 85 min écarttype  7941 Seize de 23 patient pour lesquels le délai dadministration de antibiotiques été enregistré le ont reçus en 180 min ou moins Les patient atteints de septicémie présentent diver signes cliniques et résultats de laboratoire Il est important de connaître lurgence du traitement de la septicémie et dadopter une approche organisée au sein du service pour prendre en charge le patient potentiellement septiques",
        "mesh_terms": [
            "Humans",
            "Female",
            "Ontario",
            "Retrospective Studies",
            "Male",
            "Middle Aged",
            "Sepsis",
            "Hospitals, Rural",
            "Emergency Service, Hospital",
            "Aged",
            "Adult",
            "Triage"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40785656/",
        "source_type": "Global"
    },
    {
        "pmid": "40784905",
        "title": "SARS-CoV-2 seroprevalence and COVID-19 vaccination coverage in two states of Nigeria from a population based household survey.",
        "abstract": "SARSCoV2 populationbased seroprevalence survey useful estimating extent SARSCoV2 infections may underestimated COVID19 case counts Surveys conducted October 2020 four Nigerian state showed SARSCoV2 seroprevalence ranged 93 Gombe northeast 252 Enugu southeast first COVID19 wave 100 700 time higher official number COVID19 case two states respectively conducted serosurvey second COVID19 wave evaluate extent SARSCoV2 infections attitude COVID19 vaccines COVID19 vaccination coverage two region Nigeria Using World Health Organization WHO Unity protocol 34 enumeration area EAs Federal Capital Territory FCT Northcentral Zone Kano State Northwest Zone sampled June 2021 using probability proportional estimated size 20 household one EA randomly selected consenting assenting member household asked risk behaviors adult 18 year the eligible population COVID19 vaccination Nigeria responded question COVID19 vaccine attitude receipt Blood nasaloropharyngeal sample taken consenting assenting household members Blood sample collected tested Luminex xMAP® SARSCoV2 MultiAntigen IgG Assay swab reversetranscriptasePCR RTPCR Overall response rate 768 FCT n  1505 blood draws 804 Kano State n  2178 blood draws Following second COVID19 wave Nigeria 40 resident FCT 403 95 CI 347459 Kano State 426 95 CI 394458 evidence prior SARSCoV2 infection active SARSCoV2 infection detected RTPCR either FCT Kano State FCT Kano State 34 16 people surveyed reported receipt COVID19 vaccine three month vaccine available country FCT 775 adult aware COVID19 vaccines 469 reported willingness receive them Kano State 487 adult aware COVID19 vaccines 611 willing receive them regions 84 reporting unwillingness accept COVID19 vaccine cited concern vaccine safety Serosurvey finding revealed SARSCoV2 infection far widespread Federal Capital Territory Kano State indicated reported case numbers Despite high awareness COVID19 vaccine uptake remained low primarily due concern vaccine safety result highlight urgent need targeted risk communication address vaccine hesitancy improve coverage Serosurveys provide valuable insight guide public health intervention future pandemic preparedness Nigeria",
        "mesh_terms": [
            "Humans",
            "Nigeria",
            "COVID-19",
            "Seroepidemiologic Studies",
            "Adult",
            "SARS-CoV-2",
            "Female",
            "Male",
            "COVID-19 Vaccines",
            "Middle Aged",
            "Vaccination Coverage",
            "Adolescent",
            "Young Adult",
            "Aged",
            "Surveys and Questionnaires",
            "Family Characteristics",
            "Vaccination"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40784905/",
        "source_type": "Global"
    },
    {
        "pmid": "40783765",
        "title": "Performance assessment of a ventilator developed for emergency use in a resource-constrained ICU setting during the COVID-19 pandemic.",
        "abstract": "Masi mechanical ventilator developed Peru designed manufactured rapidresponse healthcare emergency promising preclinical clinical result allowed approved national regulatory authority used emergency key feature Masi low manufacturing cost low dependence supply high volume oxygen low oxygen consumption flexibility noninvasive invasive ventilation Masi lack advanced feature found commercial ICU ventilators specifically designed shortterm use resourcelimited highdemand situation alternative conventional device unavailable study evaluates survival rate intubated COVID19 patient ventilated Masi compared conventional ventilators retrospective study conducted ICU reference hospital Lima Peru January August 2021 Medical record reviewed 77 adult patient suspected confirmed COVID19 required invasive mechanical ventilation Among them 42 patient ventilated Masi 35 commercially available ventilators Clinical characteristics laboratory findings respiratory parameters survival outcome collected analyzed survival rate relevant parameter observed patient supported Masi commercial ventilator comparable despite device limitation resourceconstrained conditions Masi ventilator functional provided essential ventilatory support healthcare emergency",
        "mesh_terms": [
            "Humans",
            "COVID-19",
            "Ventilators, Mechanical",
            "Intensive Care Units",
            "Male",
            "Middle Aged",
            "Female",
            "Retrospective Studies",
            "Health Resources",
            "Aged",
            "Adult",
            "Pandemics",
            "Respiration, Artificial",
            "Emergencies",
            "SARS-CoV-2"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40783765/",
        "source_type": "Global"
    },
    {
        "pmid": "40783709",
        "title": "Elevated MS4A12 expression is indicative of resistance to concurrent chemoradiotherapy and inferior survival in patients with rectal cancer.",
        "abstract": "individual presenting locally advanced rectal cancer therapeutic strategy neoadjuvant concurrent chemoradiotherapy CCRT aim enhance tumor downstaging however subset patient exhibit favorable response Molecular stratification combined traditional tumor staging system TNM promising approach predicting treatment efficacy patient outcomes Therefore intend better grasp molecular basis CCRT resistance guide therapeutic strategy greater precision utilized public rectal cancer transcriptomic dataset n  46 predict responsiveness neoadjuvant CCRT analyzing signal transductionrelated genes wellcharacterized rectal cancer cohort n  343 assessed correlation membranespanning 4domains A12 MS4A12 immunostaining clinicopathological characteristic using Pearsons chisquared test calculate survival rates employed KaplanMeier method logrank test Additionally conducted multivariate analysis Cox proportional hazard model identify independent prognostic biomarkers identified MS4A12 gene highly expressed rectal cancer resistant CCRT Elevated MS4A12 expression confirmed immunohistochemical staining significantly associated advanced tumor status CCRT p  0001 positive node status CCRT p  001 p  0004 presence perineural vascular invasion p  0006 p  0001 low response CCRT p  0001 Notably high MS4A12 immunoexpression strongly correlated reduced patient survival rectal cancer Mechanically high MS4A12 expression significantly associated aberrant glycosylation Bcell infiltration MS4A12 expression may offer helpful predictive prognostic indicator identifying patient could gain advantage neoadjuvant CCRT",
        "mesh_terms": [
            "Humans",
            "Rectal Neoplasms",
            "Male",
            "Female",
            "Chemoradiotherapy",
            "Middle Aged",
            "Biomarkers, Tumor",
            "Prognosis",
            "Aged",
            "Drug Resistance, Neoplasm",
            "Neoadjuvant Therapy",
            "Survival Rate",
            "Adult",
            "Membrane Proteins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40783709/",
        "source_type": "Global"
    },
    {
        "pmid": "40781799",
        "title": "Call for Standardization of C-Peptide Measurement.",
        "abstract": "impaired βcell function key contributor pathophysiology diabetes mellitus estimated biomarker Cpeptide Measurement Cpeptide therefore used prediction diagnosis subclassification diabetes Furthermore Cpeptide assist prediction therapeutic response guiding therapeutic decisions support diabetes classification American Diabetes Association ADA European Association Study Diabetes EASD recently introduced serum Cpeptide cutoff value guidelines 02 nmolL Cpeptide level suggest presence type 1 DM Cpeptide level 06 nmolL indicate type 2 DM However analytical aspect limit clinical utility defined cutoff value since standardization Cpeptide measurement achieved Results different assay manufacturer still show significant variability discrepancy significant consequences reliance Cpeptide testing diabetes classification therapeutic decision steadily increased recent years Although growing call standardize Cpeptide testing process standardization established standardization unfortunately yet implemented practice therefore seems appropriate health care provider advocate standardized Cpeptide measurements less hand manufacturer Cpeptide assays improve diagnostic accuracy patient safety",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40781799/",
        "source_type": "Global"
    },
    {
        "pmid": "40781628",
        "title": "Parenting and COVID-19: qualitative study of educational challenges, childcare and crisis-related decision-making in diplomatic families.",
        "abstract": "Diplomatic personnel played critical role looking British national COVID19 pandemic However little known experience parenting time Exploring familyrelated experience diplomatic staff pandemic important order understand unique challenge faced diplomatic family prolonged crisis identify way support them Semistructured interview carried 13 diplomatic personnel thematic analysis used analyse data Participants reported challenge relating online schooling homeschooling boarding school childcare Unique challenge reported older child neurodiverse children Quarantine evacuation necessitated pandemic left many separated child long period time Participants reported wanting greater support employer particularly greater recognition family unit challenge faced insight gained study could used diplomatic organisation multinational organisation develop policy aimed improving experience wellbeing employee family time increased global uncertainty Recommendations emerging study include ensuring that desired family kept together crisis eg choice whether evacuate duty care requirement permit arranging travel exemption diplomatic family possible making every effort reunite child parent desired respecting childcare situation defining work arrangements considering subsidy childcare diplomatic families",
        "mesh_terms": [
            "Humans",
            "COVID-19",
            "Parenting",
            "Child Care",
            "Qualitative Research",
            "Decision Making",
            "Female",
            "Male",
            "Child",
            "Adult",
            "SARS-CoV-2",
            "Family",
            "United Kingdom",
            "Pandemics",
            "Quarantine",
            "Schools"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40781628/",
        "source_type": "Global"
    },
    {
        "pmid": "40781606",
        "title": "Increase in intimate partner violence during the COVID19 lockdown in uganda: a household survey.",
        "abstract": "novel COVID19 pandemic government worldwide limited peoples movement became known lockdown contain spread infection Uganda experienced one Africas strictest longest widespread lockdowns paper examine novel COVID19 pandemic government response address impacted intimate partner violence IPV among men woman two diverse district central Uganda household survey conducted Luwero Mukono district among 1680 respondent 84 village October 25th 2021 December 3rd 2021 Data collected using standardized structured questionnaire adapted UN guideline producing statistic violence women Outcome variable lifetime current measured incident past 12 months prevalence IPV whether reported increase COVID19 lockdown assessed several item emotional socioeconomic physical sexual violence analyzed individual item derived composite variables lifetime prevalence IPV 554 higher among woman compared men 579 vs 474 p  0001 current prevalence IPV 310 4971603 higher among woman men difference reach statistical significance 322 vs 273 p  0071 these 730 363497 reported COVID19 lockdown worsened IPV experiences higher among woman men 747 vs 670 p  0113 statistically significant multivariable analysis reported increase IPV COVID19 lockdown significantly lower participant least diploma education subsistence farming selfemployed emotional violence prevalent across genders socioeconomic violence reported increased lockdown 419 experienced violence sought help majority sought help nonformal mechanism like family members IPV likely experienced woman men almost cases gender experienced IPV reported gotten worse lockdowns Pandemic preparedness government response future pandemic must consider lockdown create unintended negative consequences including exacerbating IPV",
        "mesh_terms": [
            "Humans",
            "COVID-19",
            "Uganda",
            "Female",
            "Male",
            "Intimate Partner Violence",
            "Adult",
            "Middle Aged",
            "Surveys and Questionnaires",
            "Young Adult",
            "Adolescent",
            "Prevalence",
            "Quarantine",
            "SARS-CoV-2"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40781606/",
        "source_type": "Global"
    },
    {
        "pmid": "40781483",
        "title": "Combining single-cell and bulk RNA sequencing to identify CAF-related signature for prognostic prediction and treatment response in patients with melanoma.",
        "abstract": "Cancerassociated fibroblast CAFs play complex role tumor microenvironment TME melanoma However impact prognosis treatment response melanoma remains unclear study ScRNAseq data GSE115978 utilized characterize CAF heterogeneity identify marker gene melanoma Prognostic CAF gene identified TCGA dataset employed construct risk signature subsequently validated independent cohort GSE65904 Mutation copy number variation CNV pathway enrichment immune infiltration drug sensitivity analyzed determine signatures clinical relevance Immunohistochemistry IHC immunofluorescence IF qPCR performed validate expression CAF signature clinical melanoma samples identified CAFs patient melanoma singlecell RNA sequencing data 28gene CAF signature constructed using Least Absolute Shrinkage Selection Operator LASSO regression based 271 prognostic CAF genes signature demonstrated excellent prediction accuracy survival area curve AUC value 0737 0737 0779 1year 3year 5year survival respectively signature independent prognostic factor correlated CNVs immunosuppressive TME feature reduced CD8supsup cells M1 macrophages Additionally CAF signature could predict efficacy multiple chemotherapy drug serve potential prognostic marker immunotherapy Experimental validation confirmed expression CAF signature gene melanoma tissue model may help predict prognosis response chemotherapy immunotherapy patient diagnosed melanoma",
        "mesh_terms": [
            "Humans",
            "Melanoma",
            "Prognosis",
            "Tumor Microenvironment",
            "Single-Cell Analysis",
            "Cancer-Associated Fibroblasts",
            "Female",
            "Male",
            "Biomarkers, Tumor",
            "Gene Expression Regulation, Neoplastic",
            "Sequence Analysis, RNA",
            "DNA Copy Number Variations",
            "Middle Aged",
            "Gene Expression Profiling"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40781483/",
        "source_type": "Global"
    },
    {
        "pmid": "40781349",
        "title": "Application of causal forest double machine learning (DML) approach to assess tuberculosis preventive therapy's impact on ART adherence.",
        "abstract": "Adherence antiretroviral therapy ART critical HIV treatment success yet impact tuberculosis preventive therapy TPT remains inadequately understood Using observational data 4152 HIV patient Ethiopia 20052024 applied causal inference methods including Adjusted Logistic Regression Propensity Score Matching Causal Forest Double Machine Learning DML estimate TPTs effect ART adherence DML approach leveraging Random Forests orthogonalization provided precise estimate model comparison found TPT initiation reduced adherence probability 314 percentage point average ATE   00314 95 CI  00373  00254 p  0001 patient experienced negligible effects substantial heterogeneity existed individual advanced stage longer ART duration higher BMI older age showed better adherence responses whereas higher CD4 counts functional impairment cotrimoxazole prophylaxis use faced greater risks Subgroup analysis revealed consistent effect across clinical stratum greater variability among nonTPT initiators finding support personalized TPT deployment prioritizing patient advanced disease monitoring vulnerable subgroup highlighting need adherence support Future research validate result multisite cohort using longitudinal psychosocial data",
        "mesh_terms": [
            "Humans",
            "Machine Learning",
            "Adult",
            "Female",
            "Male",
            "HIV Infections",
            "Tuberculosis",
            "Middle Aged",
            "Ethiopia",
            "Medication Adherence",
            "Anti-HIV Agents",
            "Antitubercular Agents"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40781349/",
        "source_type": "Global"
    },
    {
        "pmid": "40779038",
        "title": "End-of-life discussions, preference concordance, and good death: insights from a nationwide mortality follow-back survey.",
        "abstract": "Endoflife EOL discussion integral EOL care However whether EOL discussion improve concordance care preference care received association good death remains uncertain study aimed examine association among EOL discussions concordance patient preference EOL care familyreported good death patient cancer observational study analyzed 42379 response national mortality followback survey targeting bereaved family patients Measurements included EOL discussion regarding resuscitation preference ie code status care settings advance directive ADs concordance patient preference received care familyreported gooddeath scores EOL discussion patient physician increased concordance resuscitation preference care settings Concordance donotattempt resuscitation DNAR order increased odds ratio OR 173 95 confidence interval CI 146206 full code OR 275 95 CI 203374 Regarding care settings preferred home care showed highest concordance OR 460 95 CI 431490 ADs associated concordance full code preference OR 163 95 CI 117228 DNAR Preference concordance associated higher familyreported good death scores largest difference observed home care 714 vs 602 difference 112 95 CI 109115 EOL discussion enhanced preferenceconcordant care resuscitation preference care settings associated better familyreported good deaths finding underscore importance integrating EOL discussion routine oncology care ensure highquality EOL care consistent patient preferences",
        "mesh_terms": [
            "Humans",
            "Terminal Care",
            "Patient Preference",
            "Female",
            "Male",
            "Middle Aged",
            "Aged",
            "Neoplasms",
            "Advance Directives",
            "Resuscitation Orders",
            "Adult",
            "Family",
            "Surveys and Questionnaires",
            "Attitude to Death",
            "Aged, 80 and over"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40779038/",
        "source_type": "Global"
    },
    {
        "pmid": "40778944",
        "title": "Approaches to screening for rheumatoid arthritis-associated interstitial lung disease: a cross-sectional national survey of Turkish rheumatologists.",
        "abstract": "Rheumatoid arthritisassociated interstitial lung disease RAILD potentially lifethreatening complication RA yet standardized screening guideline lacking study aimed explore current screening practice among Turkish rheumatologist assess demographic institutional factor influence clinical decisionmaking electronic survey distributed 550 member Turkish Society Rheumatology May June 2024 questionnaire included item respondents clinical experience practice settings estimated RAILD prevalence screening criteria preferred diagnostic methods total 107 rheumatologist completed survey response rate 20 participant 598 worked university hospital 449 ≤ 5 year clinical experience half 523 estimated frequency RAILD patient 510 Nearly half rheumatologist 477 screened RA patient respiratory symptoms three frequently used screening method chest computed tomography CT 776 chest Xray 729 pulmonary function testing PFT 654 20 participant reported using single method screening preferred combination chest Xray CT PFT diffusing capacity lung carbon monoxide DLCO used 206 respondents Compared university hospitals rheumatologist working state hospital reported fewer opportunity pulmonary assessments limited access DLCO testing less collaboration experienced radiologist pulmonologists lack multidisciplinary approaches study highlight variability disease assessment clinical practice related RAILD screening among rheumatologists finding underscore need standardize screening strategies taking account national healthcare condition local working environment rheumatologists",
        "mesh_terms": [
            "Arthritis, Rheumatoid",
            "Lung Diseases, Interstitial",
            "Cross-Sectional Studies",
            "Turkey",
            "Practice Patterns, Physicians'",
            "Prevalence",
            "Rheumatologists",
            "Tomography, X-Ray Computed",
            "Diagnostic Techniques, Respiratory System",
            "Hospitals, University",
            "Hospitals, State",
            "Health Care Surveys",
            "Humans",
            "Mass Screening"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40778944/",
        "source_type": "Global"
    },
    {
        "pmid": "40775715",
        "title": "Energy intake and physical activity over the course of pregnancy and gestational weight gain: a systematic review and dose-response meta-analysis of data from randomized controlled lifestyle intervention trials.",
        "abstract": "systematic review metaanalysis aimed quantify relationship energy intake EI physical activity PA pregnancy gestational weight gain GWG randomized controlled trial RCTs RCTs measuring EI PA least twice total GWG pregnancy eligible synthesize PA measure reported different scales standardized mean change per day SMCday obtained dividing change PA standard deviation change estimated mean change EI PA mean total GWG across studies accounting clustering within studies Onestage doseresponse metaanalyses DRMA quantified additional GWG associated change EI PA pregnancy total 21 RCTs 7705 participant included mean total GWG 1199 kg 95 CI 1105 kg 1294 kg mean baseline EI 1977 kcalday across study range 1652 2777 kcalday mean increase EI throughout pregnancy 132 kcalday 95 CI 54 209 kcalday average change PA pregnancy  011 SMCday 95 CI 033 012 SMCday DRMA indicated 030 kg additional weight gain per 100 kcalday increase EI 95 CI 001 kg 060 kg P  006 effect size greater study low risk bias vs high risk bias 057 vs 020 kg P difference  002 DRMA showed 024 kg less weight gain per 025 SMCday increase PA 050 002 kg P  007 Average GWG often exceeds recommendation current guidelines particularly among woman overweightobesity OWOB average increase EI current recommendations PA level frequently observed decrease DRMA suggests GWG may modifiable change EI PA greater EI increase PA reduction linked greater GWG especially among woman OWOB Despite challenge precisely quantifying associations integrated finding comprehensive systematic review subgroupsensitivity analysis highlight need individualized nutrition exercise recommendation may warrant revisiting current guidelines",
        "mesh_terms": [
            "Humans",
            "Female",
            "Pregnancy",
            "Exercise",
            "Gestational Weight Gain",
            "Randomized Controlled Trials as Topic",
            "Energy Intake",
            "Life Style"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40775715/",
        "source_type": "Global"
    },
    {
        "pmid": "40775697",
        "title": "Online learning for crisis response: evaluating reach and perceived knowledge gains from the MOOC \"Infection, Prevention, and Control of Acute Respiratory Infections for Healthcare Workers in Low- and Middle-Income Countries (IPC MOOC)\".",
        "abstract": "COVID19 pandemic challenged healthcare system worldwide significantly affecting healthcare worker HWs particularly low middleincome country LMICs address urgent need infection prevention control IPC training among diverse healthcare roles Massive Open Online Course MOOC titled Infection Prevention Control Acute Respiratory Infections Healthcare Workers Low MiddleIncome Countries IPC MOOC developed implemented Ecuador study aimed evaluate reach perceived knowledge gain IPC MOOC focusing whether successful course completion influenced sociodemographic factor occupational role manual vs intellectual work whether satisfaction perceived learning outcome differed groups IPC MOOC developed interdisciplinary collaboration involving expert Center International Health LMU Munich University Hospital CIHsupLMUsup partner Latin America utilized problembased learning interactive scenario teach IPC principle context COVID19 course offered Ecuadorian healthcare worker August December 2021 total 3498 participant enrolling Data collected registration postMOOC survey analysed using Chisquared MannWhitney U test assess influence sociodemographic occupational factor course completion satisfaction compare perceived learning outcome manual intellectual workers enrolled participants 75 completed IPC MOOC successfully significant difference completion rate based gender region occupation Among 809 participant completed postcourse survey 80 reported high satisfaction on scale 0 100 course 95 would recommend colleagues small statistically significant difference perceived knowledge course manual intellectual worker 341 vs 357 5point Likert scale p002 postcourse perceived knowledge similar group 408 vs 414 Likert scale p041 IPC MOOC demonstrated effective accessible training tool bridging knowledge gap across diverse healthcare role promoting equitable access IPC education high completion satisfaction rate indicate potential scalable educational intervention health crisis",
        "mesh_terms": [
            "Humans",
            "COVID-19",
            "Health Personnel",
            "Ecuador",
            "Education, Distance",
            "Female",
            "Male",
            "Developing Countries",
            "Adult",
            "Respiratory Tract Infections",
            "SARS-CoV-2",
            "Health Knowledge, Attitudes, Practice",
            "Middle Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40775697/",
        "source_type": "Global"
    },
    {
        "pmid": "40775691",
        "title": "Second-hand smoke exposure level in the household increases risk of chest pain and wheezing: evidence from Qatar biobank.",
        "abstract": "Despite research association secondhand smoke exposure chest painwheezing evidence level exposure household relation outcome lacking study investigated gap Secondary data 6000 participant Qatar Biobank age 18 87 478 females consisting Qatari national longterm residents volunteered participate study provided selfreport response crosssectional survey analyzed controlled number demographic lifestyle factor studying relationship number household member smoke amount time spent home room chest painwheezing used logistic regression test crude adjusted odds ratios included planned comparison dual user cigarette shisha nonusers either product effect modification also conducted sensitivity analysis nonusers cigarette shisha strata odds chest pain adj  142 95 CI 120 168 wheezing adj  141 95 CI 111 176 higher living two smokers compared living none odds experiencing chest pain adj  151 95 CI 120 189 wheezing adj  156 95 CI 116 209 higher exposed secondhand smoke two hour per day room household smoker relative 0 h Subgroup analysis stratum neither cigarette smoker shisha user revealed people living two smokers compared none likely experience chest pain adj  149 95 CI 117 190 wheezing adj  143 95 CI 104 195 Exposure level secondhand smoke household correlate chest pain wheezing Measures reduce exposure awareness campaign needed However longitudinal examination relationship secondhand smoke household report chest pain wheezing warranted",
        "mesh_terms": [
            "Humans",
            "Qatar",
            "Female",
            "Male",
            "Tobacco Smoke Pollution",
            "Middle Aged",
            "Adult",
            "Respiratory Sounds",
            "Chest Pain",
            "Cross-Sectional Studies",
            "Aged",
            "Adolescent",
            "Young Adult",
            "Aged, 80 and over",
            "Risk Factors",
            "Biological Specimen Banks",
            "Family Characteristics"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40775691/",
        "source_type": "Global"
    },
    {
        "pmid": "40775650",
        "title": "The efficacy and peripheral blood predictors in recurrent platinum-resistant ovarian cancer patients treated with immune checkpoint inhibitors.",
        "abstract": "prognostic factor associated recurrent platinumresistant ovarian cancer treated immune checkpoint inhibitor ICI therapy need identified retrospectively analyzed efficacy ICI therapy patient recurrent platinumresistant ovarian cancer center number CD8  cell expression PDL1 assessed using immunohistochemical assays multianalyte flow assay used detect concentration 13 inflammatory cytokines univariate multivariate model constructed using pretreatment clinical variable cytokines included 71 patient recurrent platinumresistant ovarian cancer treated least two cycle antiprogrammed cell death 1 PD1 objective response rate 3662 disease control rate 7887 Elevated level interferonalpha 2 IFNα2 IL1β IL12p70 serum associated improved overall survival Higher level monocyte chemoattractant protein 1 MCP1 correlated longer overall survival progression free survival According result multivariate analysis high level Creactive protein CRP  10 independently predicted overall survival Age lowdensity lipoprotein cholesterol LDLC tumor necrosis factoralpha TNFα MCP1 independently associated progressionfree survival Chemotherapy containing platinum immunotherapy progression achieved partial response rate 5555 result ICI combination therapy demonstrated response rate one third Peripheral blood markers cytokines could potentially serve predictor immunotherapy efficacy platinumresistant ovarian cancer patients applicable",
        "mesh_terms": [
            "Humans",
            "Female",
            "Immune Checkpoint Inhibitors",
            "Ovarian Neoplasms",
            "Middle Aged",
            "Aged",
            "Drug Resistance, Neoplasm",
            "Adult",
            "Retrospective Studies",
            "Neoplasm Recurrence, Local",
            "Cytokines",
            "Platinum",
            "Prognosis",
            "Biomarkers, Tumor"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40775650/",
        "source_type": "Global"
    },
    {
        "pmid": "40775204",
        "title": "Value of serum-free light chain measurements in response and progression assessment in multiple myeloma with monoclonal protein measurable by electrophoresis.",
        "abstract": "Uniform assessment response treatment crucial managing multiple myeloma MM developing new therapies Measurement monoclonal protein form cornerstone disease assessment MM According International Myeloma Working Group IMWG guidelines serumfree light chain sFLC included MM response assessment patient measurable disease electrophoresis define stringent complete response retrospectively analyzed independent value serial FLC response progression assessment 839 patient measurable disease sFLC well serumurine electrophoresis significant association observed sFLC electrophoretic response initial therapy best response p  0001 study revealed comparable percentage change serial dFLC urine Mprotein parallel trend p  0001 strong correlation r 055079 p  0001 response detected earlier sFLC 11 months 95 CI 106117 sFLC ≥ PR two cycle induction demonstrated strong predictive value subsequent electrophoresis response OR 933 p  0001 Following induction difference PFS observed good partial response VGPR determined sFLC sPEP uPEP p  0538 median secondPFS patient sFLCprogression disease PD similar urine Mprotein PD without sFLCPD HR 128 95 CI 077213 p 0334 However median overall survival first relapse significantly better patient sFLCPD HR 187 95 CI 107327 p 003 Among patient PD 12 sFLC detectable tumor marker time secondline therapy study support incorporation serial sFLC measurement monitoring response progression MM even patient electrophoretic measurable disease advocate replacing 24h urine serial sFLC response assessment",
        "mesh_terms": [
            "Humans",
            "Multiple Myeloma",
            "Immunoglobulin Light Chains",
            "Male",
            "Female",
            "Middle Aged",
            "Aged",
            "Disease Progression",
            "Retrospective Studies",
            "Aged, 80 and over",
            "Adult",
            "Electrophoresis",
            "Myeloma Proteins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40775204/",
        "source_type": "Global"
    },
    {
        "pmid": "40774597",
        "title": "APPRAISE: A Tool for Appraising Potential for Bias in Real-world Evidence Studies on Medication Effectiveness or Safety.",
        "abstract": "Realworld evidence RWE play increasingly important role health technology assessment HTA well regulatory clinical decision making RWE studies however subject multiple source bias often easy identify impeding credibility inclusion RWE decisionmaking comprehensive fitforpurpose easytouse bias assessment tool would help streamline RWE evaluation enabling efficient utilization RWE decisionmaking globally working group International Society Pharmacoepidemiology ISPE collaborated HTA expert develop tool could guide bias assessment observational study comparative safety effectiveness medications building upon existing methodological tools best practice guidelines checklist analysis realworld data tool tested refined collaboration HTA agencies APPRAISE APpraisal Potential bias ReAl world evIdence StudiEs cover key domain bias might introduced RWE study inappropriate study design analysis exposure outcome misclassification confounding domain contains series questions Responses question autopopulate summary potential bias within domain action take avoid mitigate explore impact bias APPRAISE tool guide bias assessment observational study medication comparative effectiveness safety tool designed HTA useful many user RWE help guide optimized RWE generation",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40774597/",
        "source_type": "Global"
    },
    {
        "pmid": "40770795",
        "title": "The impact of the COVID-19 pandemic on melanoma diagnosis: a systematic review and meta-analysis of global evidence.",
        "abstract": "COVID19 pandemic significantly disrupted healthcare system worldwide Prioritizing emergency response resulted postponement routine medical care including melanoma diagnoses performed systematic review metaanalysis quantify pandemics effect diagnosis rates Breslow thickness stage presentation ulceration histologic subtypes patient age performed systematic review metaanalysis following PRISMA guidelines PubMed Scopus Web Science Embase searched 10 September 2024 observational study comparing melanoma outcome preCOVID era before March 2020 COVID era March 2020 onwards Two reviewer independently screened records extracted data diagnostic counts patient age Breslow thickness ulceration histopathological subtype assessed study quality using NewcastleOttawa Scale NOS Randomeffects model pooled rate ratio RRs odds ratio ORs fixedeffects model pooled mean difference MDs Heterogeneity evaluated I² sensitivity analysis restricted highquality study NOS ≥ 7 Sixtytwo study 38676 preCOVID 46846 COVIDera melanomas met inclusion criteria New melanoma diagnosis fell 19 pandemic RR  081 95 CI 075086 I²  98 Mean age diagnosis rose 086 year 95 CI 058114 I²  45 Tumors thicker MD  024 mm 95 CI 002047 I²  92 frequently ulcerated OR  129 95 CI 115144 I²  31 Nodular melanoma aggressive subtype became common OR  134 95 CI 108167 I²  81 whereas superficial spreading acral lentiginous lentigomaligna subtypes showed significant change key finding persisted goodqualityonly analyses COVID19related service disruption associated fewer melanoma diagnosis shift toward older patient biologically adverse tumor features signaling delayed detection population level Strengthening resilient rapidaccess skin cancer pathway integrating teledermatology triaged inperson assessment publichealth priority future crises PROSPERO registration number CRD42022361569",
        "mesh_terms": [
            "Humans",
            "Melanoma",
            "COVID-19",
            "Skin Neoplasms",
            "Pandemics",
            "Global Health"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40770795/",
        "source_type": "Global"
    },
    {
        "pmid": "40770626",
        "title": "One year on - the long-term impact of COVID-19 pandemic and government restrictions on the health-seeking behaviour, financial security and mental health of TB survivors.",
        "abstract": "People tuberculosis TB may face longterm physical psychosocialeconomic disability related TB treatment Corona Virus Disease 2019 COVID19 pandemic government restriction disrupted health care services describe healthseeking behaviour perceived financial impact mental health TB survivor one year COVID19 pandemic explore factor associated perceived impact COVID19 government restriction healthseeking behaviour crosssectional study nested ongoing observational TB Sequel cohort study Adults ≥ 18yrs completed treatment drugsusceptible pulmonary TB South Africa Gambia Mozambique start COVID19 pandemic completed COVID19 questionnaire included tool Behavioural Insights COVID19 Kessler Psychological Distress Scale K10 Medical Outcomes Short Form Survey SF36 healthrelated quality life Questionnaires administered scheduled TB Sequel followup study visit 042021 102021 used publicly available data number COVID19 case start end date wave define countryspecific COVID19 inwave outofwave phases compared psychosocial economic measure reported phases addition explored factor associated poor healthseeking behaviour comprised moderate serious impact using logistic regression Four hundred eighty seven TB survivor 69 male median age 33 year IQR 2542 median time since TB treatment completion 16 month IQR 1327 completed COVID19 questionnaire quarter TB survivor reported financial status n  117 24 healthseeking behaviour health condition n  128 26 seriously impacted COVID19 governments response third patient 304 reported using coping strategies Logistic regression indicated males living HIV antiretroviral treatment ART impacted financially COVID19 experiencing social changes associated poor healthseeking behaviour Governments response COVID19 affected TB survivors healthcareseeking behaviour financial status mental health longterm adverse effect healthseeking behaviour important TB survivor increased risk recurrent disease longterm disability first two year treatment completion Clinical trial number applicable",
        "mesh_terms": [
            "Humans",
            "COVID-19",
            "Male",
            "Female",
            "Adult",
            "Cross-Sectional Studies",
            "Patient Acceptance of Health Care",
            "Middle Aged",
            "Survivors",
            "Mental Health",
            "Surveys and Questionnaires",
            "Tuberculosis",
            "Pandemics"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40770626/",
        "source_type": "Global"
    },
    {
        "pmid": "40770131",
        "title": "Effects of sarcopenic obesity on depressive symptoms and their trajectories: findings from the CHARLS 2011-2020.",
        "abstract": "Sarcopenia obesity recognized factor associated onset depression study aim clarify specific impact sarcopenic obesity depression development longitudinal trajectory depressive symptoms Data 20112020 China Health Retirement Longitudinal Study CHARLS utilized including 8532 participant aged ≥ 45 years Cox proportional hazard regression assessed effect sarcopenic obesity incidence depression Restricted cubic spline RCS regression explored relationship component sarcopenic obesity waist circumference BMI handgrip strength appendicular skeletal muscle mass index ASMHtsup2sup depression risk Groupbased trajectory modeling GBTM identified depressive symptom trajectory among 7895 participants Multivariate logistic regression analyzed influence sarcopenic obesity covariates depressive symptom trajectories Sarcopenic nonobesity HR  115 95 CI 103128 sarcopenic obesity HR  128 95 CI 104158 associated increased depression risk RCS analysis revealed significant doseresponse relationship component sarcopenic obesity waist circumference BMI handgrip strength ASMHtsup2sup depression risk P overall trend  005 Three depressive symptom trajectory nine year identified relatively stable 481 moderate growth 418 rapid growth 101 Sarcopenic obesity OR  222 95 CI 140351 identified potential factor influencing variability depressive symptom trajectories Sarcopenic obesity associated increased risk depression may affect progression depressive symptoms Improving muscle mass strength maintaining moderate abdominal fat middleaged older adult could help prevent depression",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40770131/",
        "source_type": "Global"
    },
    {
        "pmid": "40768795",
        "title": "Immune checkpoint inhibitor-related pneumonitis: From guidelines to the front lines.",
        "abstract": "Immune checkpoint inhibitor ICIs changed cancer treatment evoking durable response various cancers However immunemediated mechanism lead unique toxicity known immunerelated adverse event irAEs among ICIrelated pneumonitis ICIP critical concern owing potential severity impact treatment continuity review provides comprehensive overview ICIP covering epidemiology pathophysiology clinical features diagnosis risk factors treatments ICIP frequently observed realworld setting clinical trials especially patient risk factor preexisting interstitial lung disease pathogenesis ICIP involves Th1Th17 inflammation autoantibody production exact mechanism remain unclear organizing pneumonialike pattern characteristic radiological finding chest computed tomography Diagnosis supported evaluation biomarkers like Krebs von den Lungen6 surfactant proteinD Highdose corticosteroid standard treatment although optimal regimen remain investigation Relapse uncommon particularly case organizing pneumonialike pattern prolonged exposure ICIs Resuming ICIs ICIP associated marked risk relapse must carefully considered Notably immune modulation ICIs may persist discontinuation potentially increasing susceptibility druginduced pneumonitis subsequent therapies use ICIs expands enhanced recognition timely intervention individualized management ICIP essential Future strategy incorporating biomarkers realworld data artificial intelligence may improve outcome patient ICIP",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40768795/",
        "source_type": "Global"
    },
    {
        "pmid": "40767796",
        "title": "Preparing for the Next Pandemic: Designing Resilient Information-Sharing Systems in Acute Care.",
        "abstract": "describe humancentered design process creating centralized digital information hub information sharing emergency department ED called E∗Drive assessed usage coronavirus 2019 COVID19 monkeypox Mpox pandemic discus replicate similar resource recruited interdisciplinary team 6 clinician designer build digital tool guiding principle reliability agility accessibility compared average unique page view EDs previous clinical guideline system tracked view alongside COVID19 Mpox case count assess E∗Drive usage pandemics process simplified complex clinical guideline singlepage colorcoded workflow could updated without specialized technical knowledge initial launch COVID19 pandemic E∗Drive httpsedriveucsfedu reached 61 unique daily user February 2023 infrastructure process enabled proactive dissemination Mpox resource well case rate rose Web traffic Mpox guideline rose San Francisco became United States epicenter Mpox peaking 126 unique daily view department staffed 25 30 clinician per day instituting clear replicable process information dissemination investing humancentered design COVID19 pandemic achieved clinician trust adoption digital information hub enabled proactive response next infectious disease outbreak Mpox using similar process offtheshelf content creation tools E∗Drive adapted many different ED setting improve information dissemination without specialized technological expertise",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40767796/",
        "source_type": "Global"
    },
    {
        "pmid": "40764647",
        "title": "Human exposure to harmful urban traffic noise pollution levels: a case study from seoul, South Korea.",
        "abstract": "Among various form environmental noise pollution urban areas road traffic noise RTN dominant source increasing risk various disease stroke heart disease diabetes Considering risks study aim evaluate RTN level across four monitoring site classified urban neighborhood categories compare WHOrecommended thresholds analyze potential adverse health effects conducted crosssectional study selecting residential areas commercial areas industrial area study sites dividing area large population high traffic volume according land use types used guideline observed adverse effect level NOAEL myocardial infarction MI nighttime whole day Lsubdensub published 2009 2018 compared RTN measurement data January December 2022 collected four monitoring sites Noise level four study site exceeded three threshold set based exposureresponse relationship RTN cardiovascular disease daytime nighttime NOAEL value 60 dBA 50 dBA nighttime threshold 45 dBA overall Lsubdensub threshold 53 dBA Furthermore degree exceeding standard value higher commercial industrial area residential areas Given detailed analyses high proportion population exposed harmful RTN contamination warrant substantial investigation policymaker action potential risks taking account regional characteristics",
        "mesh_terms": [
            "Humans",
            "Noise, Transportation",
            "Environmental Exposure",
            "Cross-Sectional Studies",
            "Seoul",
            "Environmental Monitoring",
            "Republic of Korea",
            "Myocardial Infarction"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40764647/",
        "source_type": "Global"
    },
    {
        "pmid": "40764574",
        "title": "Preparation and immunogenicity studies of NvIBDV VP2-ferritin nanoparticles.",
        "abstract": "Infectious bursal disease IBD caused infectious bursal disease virus IBDV highly contagious disease prevalent worldwide pose significant threat poultry industry commercially available vaccine used prevention IBD outbreak remain frequent continuous mutation virulent strain ability evade traditional vaccine protection complicate IBD control necessitates development novel vaccine deeper understanding viral mutation mechanisms Utilizing selfassembly capability ferritin Fe hypervariable region HVR protein novel variant IBDV NvIBDV VP2 displayed ferritin shell forming regular nanoparticles fulllength NvIBDV VP2 protein NvIBDV VP2HVRFe fusion protein prokaryotically expressed E coli purified prepare VP2 protein vaccine VP2Fe nanoparticle vaccine inactivated NvIBDV vaccine served control evaluating immunogenicity protection Recombinant prokaryotic expression vector pETVP2Fe encoding VP2HVRFe pETVP2 encoding fulllength VP2 successfully constructed Soluble VP2Fe VP2 protein expressed purified Electron microscopy confirmed formation cagelike nanoparticle structure VP2Fe Immunization SPF chicken NvIBDV VP2Fe nanoparticles induced robust immune response characterized high antibody titer significantly high protection rate viral challenge successfully constructed recombinant subunit nanoparticle vaccine display NvIBDV VP2 HVR ferritin effectively increased antibody titer provided superior immune protection approach offer feasible strategy developing novel IBDV subunit vaccines",
        "mesh_terms": [
            "Animals",
            "Nanoparticles",
            "Viral Vaccines",
            "Ferritins",
            "Infectious bursal disease virus",
            "Poultry Diseases",
            "Chickens",
            "Birnaviridae Infections",
            "Viral Structural Proteins",
            "Antibodies, Viral",
            "Immunogenicity, Vaccine"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40764574/",
        "source_type": "Global"
    },
    {
        "pmid": "40762402",
        "title": "Bridging the Digital Divide: A Multi-Method Evaluation of Nursing Readiness for Digital Health Technology.",
        "abstract": "aim study explore digital health technology readiness nurses nursing students nurseacademics nurse leadership roles Workforce digital readiness impact adoption digital health technology quality safety outcomes study sought identify key factor affecting nurses readiness specific digital health technology provide recommendation accelerate readiness level alignment rapidly advancing digital health technologies Crosssectional multimethod study online survey followed semistructured interviews Survey data N  160 analysed using descriptive inferential statistics whereas qualitative response N  8 interviews 43 openended responses thematically analysed Participants confident regarding openness innovation reporting highest confidence Levels around telehealth wearable devices information technology lowest confidence score seen health smart home technology followed health applications social media patient online resources EHRs Four theme developed qualitative interview including opportunities efficient way working digital technology turning expert novices disillusionment expectation reality shared responsibility development digital expertise Openended data focused need comprehensive education ongoing support infrastructure improvement prepare healthcare professional digital health environments Notable finding include agerelated differences need shared responsibility workforce preparation link problemsolving ability helpseeking Low confidence among nurse around use digital health technology electronic health records inhome monitoring technology wearable technology could impact adoption readiness patient safety increasingly inextricably linked digital health technologies nurse must digital health literate also included design implementation process technologies study adhered Strengthening Reporting Observational Studies Epidemiology STROBE guideline reporting crosssectional survey research Consolidated Criteria Reporting Qualitative COREQ research guidelines Limited patient public involvement incorporated focusing feedback digital health researcher practitioneracademics academic peer review process insight informed clarity relevance survey design data interpretation ensuring alignment realworld workforce development priority nursing",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40762402/",
        "source_type": "Global"
    },
    {
        "pmid": "40762147",
        "title": "Predictors of response to emergent therapies in paediatric immune thrombocytopenia.",
        "abstract": "Emergent therapy ET include intravenous immunoglobulin IVIG corticosteroid intravenous antiRhoD immunoglobulin used treat acute episode bleeding child immune thrombocytopenia ITP currently known biomarkers clinical feature predictive treatment response specific ET Thus treatment ITP remains largely trial error exposing patient potentially ineffective medications often expensive associated adverse effects therefore sought identify predictor treatment response comparison clinical characteristic paediatric patient ITP responsive ET versus nonresponsive ET identified high rate nonresponse ET cohort 511 child diagnosed ITP recent 5year period multivariable logistic regression model identified presence secondary ITP presence systemic lupus erythematosus positive baseline direct antiglobulin test DAT high baseline IgA level predictor nonresponse IVIG future management guideline incorporate predictor response could help individualize treatment patient achieving better response rate ensure less bleedingrelated morbidity avoid unnecessary side effects",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40762147/",
        "source_type": "Global"
    },
    {
        "pmid": "40760472",
        "title": "Factors associated with self-care in people with advanced chronic kidney disease and their experience of care in Catalonia: an application of Leventhal's self-regulatory model.",
        "abstract": "Although evidence demonstrated influence perception chronic kidney disease health outcome patients still gap knowledge regarding perception manifest specific population advanced chronic kidney disease ACKD study aim investigate cognitive emotional process people ACKD relation illness well examine coping strategy experience care context outpatient care southern metropolitan area Barcelona Spain qualitative study lived experience perception ACKD explored based postulate SelfRegulation Model SRM Eleven people ACKD selected primary care centre outpatient nephrology clinic referral hospital thematic analysis data carried out identifying dominant theme related mental structure coping strategy ACKD accordance concept described SRM SRM facilitated exploration understanding psychosocial factor related ACKD reported patients well diverse coping strategy adopted Health information ACKD exacerbations andor disease progression trigger cognitive representation perception weakness complex therapeutic regimens lifestyle modifications loss autonomy along emotional representation sadness fear mental construct act mediator influence coping responses facilitating adaptive strategy also potentially acting barrier effective selfcare ACKD Coping effort primarily directed preventing clinical decompensation slowing disease progression aspect process situated within healthcare institutional context characterized limited access health information poor coordination healthcare professionals fragmented continuity care Leventhals selfregulatory model facilitated understanding psychosocial factor associated ACKD reported patients well various coping strategy employed Findings highlight individual manage ACKD based cognitive emotional structures supporting future SRM applications Educational intervention strengthen identity promote coping strategy addressing barriers explore emotional impacts Additionally healthcare strategy enhance professional awareness improving health education care continuity",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Self Care",
            "Renal Insufficiency, Chronic",
            "Middle Aged",
            "Spain",
            "Adaptation, Psychological",
            "Aged",
            "Qualitative Research",
            "Adult",
            "Self-Control",
            "Models, Psychological"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40760472/",
        "source_type": "Global"
    },
    {
        "pmid": "40760031",
        "title": "Leveraging geographic information system for dengue surveillance: a scoping review.",
        "abstract": "Vectorborne disease caused Aedes mosquito remain major public health concern across tropical subtropical regions Geographic Information Systems GIS become integral surveillance enabling spatial analysis risk mapping predictive modelling scoping review explores GIS applied surveillance study identifies potential applications key variables modelling approaches challenges scoping review conducted following PRISMAScR guideline structured using search strategy identify relevant peerreviewed article published 2015 2024 across database like PubMed Scopus ScienceDirect Google Scholar total 64 study selected charted based geographic focus GIS applications modelling techniques spatial methods key variables notable concentration study found South Southeast Asia reflecting high disease burden research activity regions ArcGIS QGIS frequently used platform dengue surveillance around globe Risk mapping hotspot detection frequent targeted application n  26 followed vector control monitoring n  23 Environmental climatic variable commonly analysed including temperature rainfall humidity Normalised Difference Vegetation Index Common analytical method included regressionbased spatial model and increasingly machine learning technique along GIS Emerging trend include integrating machine learning models remote sensing data mobile GIS realtime monitoring early warning systems GIS evolved mapping tool multidimensional decisionsupport system disease surveillance integration environmental climatic demographic data enables proactive outbreak management targeted interventions Future research leverage Artificial Intelligence machine learning Internet Things participatory GIS interdisciplinary data enhance surveillance prediction public health response Strengthening collaborative datasharing framework incorporating machinelearning approach could improve effectiveness GISdriven surveillance programs",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40760031/",
        "source_type": "Global"
    },
    {
        "pmid": "40759918",
        "title": "Self-reported prevalence and associated factors of work related voice disorders among school teachers in Sekota town, Wag Himra zone, North Ethiopia, 2021: a cross-sectional survey.",
        "abstract": "Occupational dysphonia workrelated voice disorder common problem among school teachers Voicerelated absenteeism treatment expenses societal cost US alone estimated 25 billion dollar annually Worldwide many study conducted however Ethiopia study investigated teachers voice disorders epidemiology magnitude voice problem among Ethiopian teacher still unknown study aimed investigate prevalence associated factor workrelated voice disorder among school teacher Sekota town wag himra zone Ethiopia Crosssectional survey conducted 586 school teacher worked public school Sekota town wag himra zone April 1 May 30 2021 participant chosen using census pretested selfadministered Voice Handicap Index10 VHI10 scale questionnaire used obtain information voice disorder associated factors Epidata 46 SPSS version 25 used data entry analysis respectively Univariate Multivariate logistic regression analysis carried ascertain association dependent independent variables 95 confidence interval CI used identify factor significantly associated voice disorder pvalue ≤ 005 total 586 respondent participated response rate 921 549 322586 participant males prevalence workrelated voice disorder among school teacher past 12 month 21 95 CI 178245 primary school teacher 248 secondary school teacher 193 teacher college 157 Technical Vocational Education Training TVET 115 Infrequent nasal allergy AOR27495 CI 153489 nasal allergy sometimes AOR53895CI 2101377 teaching consecutive 5th 6th class AOR 56495CI1621967 speak natural breath cycleAOR39495CI 131190 rarely drunk alcohol AOR62895 CI 253156 sometimes drunk alcohol AOR32795 CI 13281 taking medication AOR95295 CI 1824986 stress anxiety AOR23295 CI 104515 noise child playing outside AOR3195 CI 145643 found significantly associated factor workrelated voice disorders study concludes workrelated voice disorder common occupational hazard among school teachers Provided voice problem may preventable greatly affect performance quality life intervention paramount Therefore recommend developing prevention program including preventive voice training voice hygiene sanitary work condition combat functional voice disorder among school teachers",
        "mesh_terms": [
            "Humans",
            "Cross-Sectional Studies",
            "Male",
            "Ethiopia",
            "Female",
            "School Teachers",
            "Prevalence",
            "Adult",
            "Voice Disorders",
            "Occupational Diseases",
            "Middle Aged",
            "Self Report",
            "Risk Factors",
            "Surveys and Questionnaires"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40759918/",
        "source_type": "Global"
    },
    {
        "pmid": "40758733",
        "title": "Non-communicable disease care for persons living with HIV in Peru: A national physician cross-sectional study.",
        "abstract": "Noncommunicable disease NCDs significant cause morbidity mortality aging HIV population worldwide Peru data exists provider address NCDs person living HIV PLWH study examines HIV physician confidence current management practice NCDs PLWH Peru recruited publicsector HIV physician via Perus National HIV STI Hepatitis Programs NHSTIHP physician registry program coordinator referral Participants completed telephone survey encompassing seven NCDs hyperlipidemia hypertension diabetes osteoporosis sarcopenia nonAIDS defining cancers neurocognitive impairment NCI three modifiable risk factor obesity tobacco alcohol use Survey domain included 1 provider practice characteristic 2 NCDs encountered 3 provider confidence prevention diagnosis treatment based upon fourpoint Likert scale 4 screening frequency management approach free response obtained contact information 167 physician working NHSTIHP 78 47 volunteered participate mean age 458 ± 93 years 26 women 78 infectious disease trained across 23 25 region Peru majority 50 physician reported least one patient with hyperlipidemia hypertension diabetes NCI cervical cancer obesity tobacco andor alcohol use Physicians felt confident independently managing metabolic disorder hyperlipidemia diabetes hypertension obesity least confident NCI sarcopenia physician 50 would manage NCDs although management approach differed NCD screening part NHSTIHP National HIV care guideline consistently performed screening beyond scope existing guidelines Peruvian HIV physician encounter NCDs patient population manage condition risk factor despite variable confidence andor knowledge best practices study highlight opportunity expanding physician education addressing systemslevel barrier NCD care need locally relevant epidemiologicallybased HIVspecific NCD care guidelines",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40758733/",
        "source_type": "Global"
    },
    {
        "pmid": "40758702",
        "title": "What we can and cannot see from the surveillance for drug-resistant Pseudomonas aeruginosa-Findings from the evaluation of a surveillance system for multidrug-resistant P. aeruginosa infections in Japan.",
        "abstract": "Antimicrobial resistance Pseudomonas aeruginosa one global health concerns Like many countries Japan monitor multidrugresistant P aeruginosa MDRP infection national sentinel surveillance system shown recent decline MDRP reports evaluated surveillance system verify validity trend explore future directions conducted crosssectional mixedmethod study based mainly guideline published United States Centers Disease Control Prevention 2001 quantitative method analyzed characteristic report MDRP infection designated sentinel site DSSs 20132022 questionnaire sent identifiable DSSs target DSSs requesting data accurate number MDRP infection 20182022 assess attribute geographical representativeness Additionally conducted qualitative method facetoface semistructured key informant interview surveillance system stakeholder assess usefulness challenges 2013 2022 1666 case MDRP infection reported 463 target DSSs scattered across county obtained valid response questionnaire survey 231 target DSSs 499 2018 2022 site reported 277 case MDRP infections 184 case accurate case MDRP infection number declining time False reporting underreporting MDRP infection common resulting positive predictive value 045 sensitivity 065 report MDRP infection surveillance system interview highlighted difficulty timely detection accurate reporting international data comparison evaluation indicated current sentinel surveillance system MDRP infection partially captured true decreasing trend Japan However epidemiology drugresistant P aeruginosa changing national policy surveillance strategy would need address changing public health needs",
        "mesh_terms": [
            "Japan",
            "Pseudomonas aeruginosa",
            "Humans",
            "Pseudomonas Infections",
            "Drug Resistance, Multiple, Bacterial",
            "Cross-Sectional Studies",
            "Sentinel Surveillance",
            "Surveys and Questionnaires",
            "Anti-Bacterial Agents",
            "Male",
            "Female"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40758702/",
        "source_type": "Global"
    },
    {
        "pmid": "40756930",
        "title": "Impact of COVID-19 on Maxillofacial Surgical Services in Africa: Implications for Future Practice.",
        "abstract": "determine impact COVID19 pandemic maxillofacial surgical service institutional preparedness similar pandemic Africa crosssectional survey oral maxillofacial OMF surgeon senior registrar practiced Africa COVID19 pandemic undertaken survey presented English French language reach almost OMF surgeon Africa Responses deidentified analyzed using SPSS version 25 Respondents 69 hospital located 34 city 16 African countries participated study practice University Teaching hospital 667 public hospital 275 private hospital 58 COVID19 pandemic restriction affected service 49 710 hospital offered service limited trauma infection oncology Practice infection control guideline provided 66 956 hospitals Fiftytwo respondent collected specimen COVID19 screening patients 39 565 positive 275 respondent perceived institution appreciated need preparedness future outbreak 391 uncertain institution did Preparedness handle similar situation future low COVID19 pandemic restricted practice full scope OMFS Africa comprehensive review event development institutional policy practice effectively combat future pandemic needful",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40756930/",
        "source_type": "Global"
    },
    {
        "pmid": "40755255",
        "title": "Pretreatment CT Texture Analysis for Predicting Survival Outcomes in Advanced Nonsmall Cell Lung Cancer Patients Receiving Immunotherapy: A Systematic Review and Meta-Analysis.",
        "abstract": "established biomarkers predict immunotherapy response advanced nonsmall cell lung cancer NSCLC additional noninvasive imaging biomarkers may enhance treatment selection Pretreatment computed tomography CT texture analysis may provide tumor characterization predict survival outcomes conducted systematic review metaanalysis following Preferred Reporting Items Systematic Reviews MetaAnalyses PRISMA guidelines PubMed Cochrane Library database searched Study quality assessed using quality prognosis study QUIPS tool Hazard ratio HRs 95 confidence interval CIs pooled using randomeffects models Ten retrospective study involving 2400 patient included Patients stratified lowrisk based CT texture feature demonstrated significantly improved survival outcome compared highrisk patients included study used diverse radiomic feature risk stratification including texture feature graylevel cooccurrence matrix GLCM entropy dissimilarity firstorder statistical parameter including skewness kurtosis graylevel runlength matrix GLRLM features deep learningderived features Metaanalysis five study n  1102 revealed patient stratified lowrisk based quantitative CT texture signature substantially better overall survival OS p  00001 minimal heterogeneity Isup2sup  00 Similarly progressionfree survival PFS analysis five study n  1799 showed significant benefit lowrisk patient p  00001 though moderate heterogeneity Isup2sup  717 Pretreatment quantitative CT texture analysis effectively predicts survival outcome advanced NSCLC patient receiving immunotherapy providing clinically meaningful risk stratification noninvasive imaging approach may serve additional tool complement established pathological molecular biomarkers including liquid biopsy enhanced personalized treatment selection",
        "mesh_terms": [
            "Humans",
            "Carcinoma, Non-Small-Cell Lung",
            "Immunotherapy",
            "Lung Neoplasms",
            "Prognosis",
            "Tomography, X-Ray Computed"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40755255/",
        "source_type": "Global"
    },
    {
        "pmid": "40754226",
        "title": "Scabies: An updated review from epidemiology to current controversies and future perspectives.",
        "abstract": "Scabies highly contagious parasitic dermatosis caused mite Sarcoptes scabiei var hominis affecting 200 million individual globally imposing significant health burden Traditionally linked low socioeconomic status overcrowding prevalence rising globally especially among urban institutional settings Beyond cutaneous manifestations secondary bacterial complication contribute significant morbidity particularly endemic areas Advances noninvasive imaging technique including ultraviolet dermoscopy reflectance confocal microscopy linefield confocal optical coherence tomography improved diagnostic accuracy molecular assay show promise enhanced sensitivity Conventional diagnostics remain dependent clinical evaluation microscopic identification mites eggs scybala Firstline treatment involves topical systemic therapies topical permethrin benzyl benzoate oral ivermectin commonly recommended international guidelines Emerging drug resistance prompted research toward optimizing drug regimen novel therapies including moxidectin combination treatments Outbreaks scabies institutional settings well endemic disease limited resources demonstrate importance coordinated public health effort form early case detection simultaneous treatment contact environmental control measures review present updated thorough description scabies covering relevant epidemiology clinical picture new diagnostic methods summary combining new update essential unanswered questions review describes current dilemma cover latest data field",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40754226/",
        "source_type": "Global"
    },
    {
        "pmid": "40753232",
        "title": "The role of irregular eating behaviors in metabolic dysfunction-associated steatotic liver disease: evidence from a multicenter cross-sectional study in China.",
        "abstract": "Irregular eating patterns skipping breakfast late dinner consumption linked adverse metabolic profiles However impact behavior combined effect metabolic dysfunctionassociated steatotic liver disease MASLD remains unclear multicenter crosssectional study analyzed data 1965 adult recruited diabetes obesity metabolic disease clinic six municipalitiesprovinces China Participants categorized analysis based two irregular eating habit assessed monthly frequency skipping breakfast late dinner consumption individual analyses habit treated binary variable dividing participant two group eg skipper vs nonskippers combined analysis habit aggregated form threelevel ordinal variable classified participant based number habit reported No zero Medium one Severe both employed logistic regression model calculate odds ratio ORs MASLD associated skipping breakfast late dinner consumption combination adjusting key demographic lifestyle metabolic factors prevalence MASLD higher among breakfast skipper compared ate breakfast regularly 529 vs 472 p  0023 similarly higher among late dinner eater compared regular dinner time 544 vs 468 p  0003 combined analysis graded relationship observed across threelevel ordinal variable MASLD prevalence increasing 465 No irregular eating group 503 Medium irregular eating group 555 Severe irregular eating group p  001 multivariable adjustment skipping breakfast late dinner consumption combination behavior independently associated higher odds MASLD highlighted clear doseresponse relationship combined behaviors odds MASLD systematically increased severity irregular eating from No Medium Severe Notably Severe irregular eating group representing habits 65 higher odds MASLD compared none OR  165 95 CI 117234 p  0004 study indicates irregular eating behaviors skipping breakfast late dinner consumption well combination significantly associated higher prevalence MASLD",
        "mesh_terms": [
            "Humans",
            "Cross-Sectional Studies",
            "China",
            "Male",
            "Female",
            "Feeding Behavior",
            "Middle Aged",
            "Fatty Liver",
            "Adult",
            "Metabolic Diseases",
            "Prevalence",
            "Odds Ratio"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40753232/",
        "source_type": "Global"
    },
    {
        "pmid": "40753231",
        "title": "Prevalence and predictors of poor oral health-related quality of life among the Saudi elderly.",
        "abstract": "Oral healthrelated quality life OHRQoL among Saudi senior population investigated Yet study conducted confined area city smaller sample sizes using different OHRQoL measures none mentioned rate poor OHRQoL Thus study aimed determine prevalence predictor poor OHRQoL elderly Saudi Arabians using Oral Health Impact Profile OHIP14 anonymous Arabicvalidated OHIP14 questionnaire used communitybased crosssectional study 706 senior citizen Saudi Arabia utilizing SurveyMonkey seven domain OHIP14 two question must answered 5point Likert scale score ranging 0 56 Higher score indicated poorer QoL Poor QOL reported answered fairly often very often least once Participant demographics dental healthcare behaviors perceived oral health OH status gathered Logistic regression analysis used find predictor poor OHRQoL Poor OHRQoL noted nearly half individual 475 domain largest percentage physical pain 408 followed physical disability 234 psychological disability 228 domain lowest percentage social disability 135 smoking significant risk factor OR  194 95 CI 108348 p  0027 poor OHRQoL dental insurance OR  064 95 CI 047090 p  0001 positive perception OH status OR  041 95 CI 030054 p  0001 significant protective factor controlling potential confounders Nearly half Saudi Arabias elderly population poor OHRQoL Smoking major risk factor poor OHRQoL dental insurance significant protective factor positive perceived OH status indicates good OHRQoL Health education seminar quitting smoking conducted Elderly peoples dental insurance top priority",
        "mesh_terms": [
            "Humans",
            "Saudi Arabia",
            "Quality of Life",
            "Oral Health",
            "Male",
            "Female",
            "Aged",
            "Cross-Sectional Studies",
            "Prevalence",
            "Surveys and Questionnaires",
            "Middle Aged",
            "Aged, 80 and over"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40753231/",
        "source_type": "Global"
    },
    {
        "pmid": "40751877",
        "title": "Sequential use of OnabotulinumtoxinA and Erenumab in Chronic Migraine: Retrospective Real-World Report on Bidirectional Switching.",
        "abstract": "clinical practice switching preventive treatment common patient chronic migraine efficacy insufficient tolerability poor advent targeted therapies onabotulinumtoxinA calcitonin generelated peptide CGRP monoclonal antibodies treatment option expanded yet evidence guide sequencing decision remains limited aim study investigate realworld effectiveness switching onabotulinumtoxinA erenumab vice versa patient chronic migraine showed inadequate response initial preventive treatment retrospective realworld study included patient chronic migraine treated Headache Center CharitéUniversitätsmedizin Berlin October 2022 December 2024 Eligible patient received onabotulinumtoxinA erenumab sequence switching result insufficient efficacy tolerability good response defined ≥ 50 reduction monthly headache day third month switch 632 screened patients 78 met inclusion criterion 846 female mean age 43 ± 14 years these 54 switched onabotulinumtoxinA erenumab 24 erenumab onabotulinumtoxinA good response observed 14 patient 179 1054 185 switching erenumab 424 167 switching onabotulinumtoxinA Sequential preventive treatment onabotulinumtoxinA erenumab resulted good response onefifth patients Although treatment target CGRP pathway distinct mechanism action may still provide benefit switching therapy initial failure",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40751877/",
        "source_type": "Global"
    },
    {
        "pmid": "40751236",
        "title": "Investigating key factors influencing substance abuse among undergraduate medical students at Saint Paul's hospital millennium medical college, Addis Ababa, Ethiopia: a qualitative approach.",
        "abstract": "Substance abuse prevalent among college students especially low middleincome country like Ethiopia study explored factor influencing substance abuse among medical students particularly neglected Ethiopian context study aim fill gap qualitative exploration providing insight crucial intervention treatment strategies study aimed understand primary influencers contributing substance abuse among undergraduate medical student Saint Pauls Hospital Millennium Medical College exploratory qualitative study design employed March 2023 May 2023 Saint Pauls Hospital Millennium Medical College Indepth interview conducted seven substanceabusing student selected via snowball sampling interview explored experiences challenges perceptions Thematic analysis utilized identify categorize emergent themes study found khat alcohol cigarette perceived commonly abused substance among medical students Psychosocial economic factors medical school environment challenge cessation identified significant influencers substance abuse finding organized four main theme six subthemes derived thematic analysis Psychosocial economic factors medical students contribute substance abuse study recommends college intervention strengthening support group campus activities Policy change enforcing stricter substance control government also suggested mitigate substance abuse among medical students",
        "mesh_terms": [
            "Humans",
            "Ethiopia",
            "Students, Medical",
            "Female",
            "Qualitative Research",
            "Male",
            "Substance-Related Disorders",
            "Young Adult",
            "Adult",
            "Catha",
            "Schools, Medical"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40751236/",
        "source_type": "Global"
    },
    {
        "pmid": "40751221",
        "title": "Adverse childhood friendship and depression in later life: findings from a national survey in China.",
        "abstract": "explore relationship childhood friendship depression among older adult China provide evidence policymaking promote mental health older adult novel perspective Data China Longitudinal Study Health Retirement CHARLS used study Logistic regression model adopted assess association childhood friendship depression symptoms Additionally trend test used investigate possible doseresponse relationships total 6395 participant aged 60 included study adjusting covariates individual poor childhood friendship experience showed higher risk latelife depression compared respondent better friendship experience childhood OR  164 95 CI 122221 P  0001 Cumulative childhood friendship score associated latelife depression exhibited dose response Friendshiprelated loneliness closely associated depression later life compared low friendship frequency low friendship quality OR  058 95 CI 048068 P  0001 association childhood friendship latelife depression particularly significant younger less educated people addition association statistically significant subgroup based sex address Poor childhood friendship experience independent risk factor depression later life Healthrelated department emphasize construction good relationship early life prevent occurrence depression later life",
        "mesh_terms": [
            "Humans",
            "Male",
            "China",
            "Female",
            "Friends",
            "Aged",
            "Middle Aged",
            "Longitudinal Studies",
            "Depression",
            "Adverse Childhood Experiences",
            "Loneliness",
            "Aged, 80 and over",
            "Risk Factors",
            "Child"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40751221/",
        "source_type": "Global"
    },
    {
        "pmid": "40751080",
        "title": "Knowledge, attitudes, and practices among patients with diabetic foot ulcers towards disease management.",
        "abstract": "study aimed assess knowledge attitude practice KAP among patient diabetic foot ulcer toward disease management webbased crosssectional study conducted April December 2023 Zhangzhou Affiliated Hospital Fujian Medical University Patients diagnosed diabetic foot ulcer invited participate structured selfadministered questionnaire used collect data demographic characteristics KAP related diabetic foot ulcer management total 508 valid response analyzed Pearsons correlation analysis path analysis performed explore relationship among knowledge attitudes practices selfdesigned questionnaire designed gather demographic information patient diabetic foot ulcer assess KAP toward disease management total 508 valid questionnaire collected Among participants 273 5374 male 345 6791 elder 60 year old 393 7736 resided rural area 470 9252 reported engaging regular exercise mean knowledge attitudes practice score 615 ± 154 possible range 011 3549 ± 287 possible range1260 2681 ± 260 possible range 1050 respectively path analysis demonstrated knowledge exerted direct influence attitude β  0751 P  0001 practice β  0380 P  0001 additional indirect effect practice attitude β  0332 P  0001 Furthermore attitude demonstrated direct impact practices indicated path coefficient 0442 P  0001 Patients diabetic foot ulcer showed good knowledge positive attitudes yet specific deficiency remain highlighting need ongoing patient education healthcare support",
        "mesh_terms": [
            "Humans",
            "Diabetic Foot",
            "Male",
            "Female",
            "Health Knowledge, Attitudes, Practice",
            "Middle Aged",
            "Surveys and Questionnaires",
            "Cross-Sectional Studies",
            "Aged",
            "Adult",
            "Disease Management"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40751080/",
        "source_type": "Global"
    },
    {
        "pmid": "40750284",
        "title": "Towards novel BIOmarkers to diagnose SEPsis (BIOSEP) in the emergency room: a protocol for a multicentre, prospective cohort study.",
        "abstract": "international Surviving Sepsis Campaign guideline highlight need recognising sepsis timely accurate manner Early diagnosis treatment sepsis crucial associated reduced mortality early stage sepsis heterogeneous clinical sign difficult interpret often leading missed delayed diagnoses well inappropriate late use antibiotics urgent need quickly accurately identify patient potential infection emergency department ED risk progressing along infectionsepsis spectrum study aim compare immune response ED patient presenting suspected infection without sepsis gain insight immune aberration identify novel biomarkers linked increased risk developing sepsis sequelae prospective observational cohort study across three hospital Netherlands conducted Adults presenting ED hospitals suspected infection Modified Early Warning Score 2 higher eligible enrolment aim include 3330 patients main study parameter characterisation host immune metabolic response using multiomics analysis Raman spectroscopy mass spectrometry gut microbiota profiling relation clinical outcome 30day mortality length hospital stay readmission postsepsis sequelae Verbal written informed consent obtained participant legal representatives study approved Amsterdam University Medical Centre Ethics Committee No 20220279 adhere Declaration Helsinki Medical Research Involving Human Subjects Act WMO Research result published peerreviewed journals ClinicalTrialsgov NCT06178822",
        "mesh_terms": [
            "Humans",
            "Biomarkers",
            "Emergency Service, Hospital",
            "Sepsis",
            "Prospective Studies",
            "Netherlands",
            "Multicenter Studies as Topic",
            "Observational Studies as Topic",
            "Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40750284/",
        "source_type": "Global"
    },
    {
        "pmid": "40746695",
        "title": "Factors influencing implementation of a self-measured blood pressure program in community health centers: an implementation mapping approach.",
        "abstract": "Uncontrolled hypertension leading cause cardiovascular disease particularly among adult aged 45 year older Selfmeasured blood pressure SMBP evidencebased intervention help patient manage hypertension outside clinical setting conducted need asset assessment identify 1 health center adopter implementers 2 barrier facilitator SMBP adoption implementation six community health center Texas Data source included 1 need asset assessment survey semistructured interviews 2 site visit participating health centers 3 detailed meeting note logs Leaders administrator participating health center completed selfadministered 56item survey computed descriptive statistic survey data openended survey responses interview data meeting notes team member labeled reported observed barrier facilitator program implementation Barriers SMBP adoption implementation included staffing shortages limited funding procure blood pressure devices perceived challenge reaching patient maintaining engagement SMBP program Facilitators included existing hypertension management guidelines health center familiarity SMBP programs use nonphysician team member hypertension management programs Adopters included leadership professional administrators implementers included healthcare providers nonphysician team members Findings inform understanding SMBP program adoption implementation importantly best allocate resource incorporate SMBP program clinical workflows",
        "mesh_terms": [
            "Humans",
            "Hypertension",
            "Community Health Centers",
            "Texas",
            "Middle Aged",
            "Female",
            "Male",
            "Blood Pressure Determination",
            "Surveys and Questionnaires",
            "Aged",
            "Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40746695/",
        "source_type": "Global"
    },
    {
        "pmid": "40742623",
        "title": "Factors Influencing Treatment Adherence in Chronic Spontaneous Urticaria: A Systematic Review.",
        "abstract": "Chronic spontaneous urticaria CSU characterized recurrent wheal andor angioedema without identifiable trigger Despite advance therapyincluding biologics omalizumabsuboptimal treatment adherence remains major challenge often resulting poor symptom control diminished quality life objective study evaluate existing literature adherence CSU identify evidencebased strategy improving longterm treatment engagement systematic literature search PubMed EMBASE performed article published 2000 2024 using term chronic spontaneous urticaria chronic urticaria chronic idiopathic urticaria compliance adherence Eligible study reported original data adherencerelated factor CSU study categorized World Health Organization WHO adherence dimensions socialeconomic healthcare system conditionrelated therapyrelated patientrelated Risk bias assessment conducted study included final selection search followed PRISMA guidelines protocol registered PROSPERO ID CRD42024627967 Twentyone study totaling 18500 patients met inclusion criteria Common barrier included lack preventative medication use inconvenience forgetfulness dissatisfaction healthcare providers logistical challenge accessing inoffice biologic administration Patients previously treated immunosuppressant poorer response omalizumab may contribute nonadherence due perceived lack efficacy External factor COVID19 pandemic also contributed nonadherence reducing clinic visit access specialist referrals Higher education level employment significantly associated improved adherence Proposed strategy include simplifying treatment regimens enhancing patient education CSU chronicity providing telehealth home medication administration options offering financial social support programs Multiple interrelated barrier contribute treatment nonadherence patient CSU underscoring need multifaceted patientcentered interventions Clear communication simplified regimens supportive resource may enhance adherence help achieve improved longterm clinical outcomes",
        "mesh_terms": [
            "Humans",
            "Chronic Urticaria",
            "Medication Adherence",
            "Omalizumab",
            "Quality of Life"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40742623/",
        "source_type": "Global"
    },
    {
        "pmid": "40740293",
        "title": "Risk of clinical events in virologically suppressed people with HIV switching to a two-drug regimen vs. remaining on a three-drug regimen: a target trial emulation.",
        "abstract": "Guidelines support switch twodrug regimen 2DR virologically suppressed people HIV PWH threedrug regimen 3DR Randomized clinical trial included clinical outcome study endpoints provide estimate 3year clinical risk mean target trial emulation using data large cohort PWH Italy PWH Icona Foundation Study virologically suppressed HIVRNA ≤50 copiesmL ≥6 month 3DR November 2014 enrolled database closure July 31 2024 PWH classified according therapeutic strategies switching 2DR protease inhibitor dolutegravir plus lamivudine dolutegravir plus rilpivirine remaining 3DR any combination primary endpoint time first clinical composite event cardiovascular disease CVD cancer AIDS nonAIDS related death calculated difference 3year risk therapeutic strategies estimated using weighted nonparametric KaplanMeier estimator 7672 participant entered analysis 629 82 switching 2DR 7043 918 remaining 3DR 3year followup 408 event registered 64 CVD 234 cancer 110 deaths 3year adjusted risk estimate 255 95 CI 172 533 2DR vs 469 95 CI 448 617 3DR difference 215 95 CI 356 020 favor 2DR mainly driven event nonAIDS related cancer mortality study provides evidence virologically suppressed PWH safely switched 2DR may slightly reduce 3year risk composite clinical outcome Icona Foundation Study supported unrestricted grant Gilead Sciences ViiV Healthcare Merck Sharpe  Dohme",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40740293/",
        "source_type": "Global"
    },
    {
        "pmid": "40739245",
        "title": "Free prostate-specific antigen, total prostate-specific antigen, and their ratio associated with diabetic kidney disease: new evidence from male patients with diabetes in the United States.",
        "abstract": "examine association prostatespecific antigen PSArelated biomarkers diabetic kidney disease DKD male patient diabetes study utilized data National Health Nutrition Examination Survey NHANES conducted 2001 2010 including 1681 male diabetic patient 409 DKD Multivariable logistic regression model adjusted age race body mass index BMI hypertension cardiovascular disease employed evaluate relationship total PSA TPSA free PSA FPSA FPSATPSA ratio DKD Doseresponse curve subgroup analysis performed assess associations Elevated level TPSA FPSA FPSATPSA ratio significantly associated increased risk DKD fully adjusted models highest tertiles TPSA OR  192 95 CI 143256 FPSA OR  269 95 CI 200360 demonstrated strongest associations FPSATPSA ratio exhibited linear doseresponse relationship DKD OR  216 95 CI 160291 whereas TPSA FPSA showed nonlinear threshold effects Subgroup analysis confirmed consistent finding across populations PSArelated biomarkers may serve potential indicator early diagnosis risk stratification DKD validation study mechanistic investigation necessary optimize clinical intervention improve renal outcome diabetic patients",
        "mesh_terms": [
            "Humans",
            "Male",
            "Prostate-Specific Antigen",
            "Diabetic Nephropathies",
            "Middle Aged",
            "United States",
            "Nutrition Surveys",
            "Aged",
            "Biomarkers",
            "Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40739245/",
        "source_type": "Global"
    },
    {
        "pmid": "40739215",
        "title": "Concurrent nonalcoholic fatty liver disease may decrease liver fibrosis severity in patients with primary biliary cholangitis.",
        "abstract": "purpose study evaluate nonalcoholic fatty liver disease NAFLD impact progression prognosis primary biliary cholangitis PBC retrospective study enrolled patient diagnosed PBC NAFLD patient identified according 2023 American Association Study Liver Diseases guidelines primary outcome measured percentage patient achieving complete biochemical response defined Paris criteria secondary outcome included noninvasive fibrosis scoring system transplantationfree survival risk model Statistical analysis employed independent sample Students ttest MannWhitney U test continuous variable Pearsons chisquare Fishers exact test categorical variables significance set twotailed Pvalue less 005 Among 363 patient diagnosed PBC 87 240 also diagnosed NAFLD Biochemical response rate differ significantly patient PBC concurrent PBC NAFLD P005 However one year ursodesoxycholic acid UDCA treatment significant difference observed aspartate aminotransferasetoplatelet ratio index APRI fibrosis 4 FIB4 score PBC patient without NAFLD APRI 035 vs 047 P  002 FIB4 score 195 vs 253 P  001 GLOBE score revealed patient PBC NAFLD higher 5 10 15year liver transplantfree survival rate compared PBC 819 583 380 respectively P  005 Patients concurrent PBC NAFLD significantly impact biochemical response UDCA may improve degree liver fibrosis longterm prognosis",
        "mesh_terms": [
            "Humans",
            "Non-alcoholic Fatty Liver Disease",
            "Male",
            "Female",
            "Middle Aged",
            "Retrospective Studies",
            "Liver Cirrhosis, Biliary",
            "Severity of Illness Index",
            "Liver Cirrhosis",
            "Disease Progression",
            "Ursodeoxycholic Acid",
            "Aged",
            "Adult",
            "Prognosis",
            "Cholagogues and Choleretics",
            "Aspartate Aminotransferases"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40739215/",
        "source_type": "Global"
    },
    {
        "pmid": "40739213",
        "title": "Reporting and handling of missing data in published studies of co-morbid hypertension and diabetes among people living with HIV/AIDS: a systematic review.",
        "abstract": "hypertension diabetes emerge comorbidities among people living HIVAIDS PLWH need robust epidemiological research inform policy action imperative Proper reporting handling missing data crucial study avoid loss statistical power precision generate unbiased results aimed assess reporting handling missing data published study comorbid hypertension diabetes among PLWH searched PubMed crosssectional study comorbid hypertension diabetes among PLWH published worldwide January 1990 June 2023 extracted data reporting missing data quantity type occurred bias assessment handled 2179 record identified 154 study included among 53 344 reported missing data primarily within exposure variable CD4 count viral load 19 study 377 cited reason missingness predominantly attributed lack documentation nonresponse 24 455 study detailed handled missing data majority 16 studies 302 used complete case analysis 553 study 943 adopted multiple imputation methods potential bias introduced missing data acknowledged 1253 226 studies reporting handling missing data hypertension diabetes study among PLWH currently suboptimal Enhanced understanding data missing choosing appropriate method address paramount reduce potential biases Adopting adhering comprehensive guideline managing missing data pressing need ensure accurate result better represented PLWH population",
        "mesh_terms": [
            "Humans",
            "Hypertension",
            "Diabetes Mellitus",
            "HIV Infections",
            "Comorbidity",
            "Research Design",
            "Cross-Sectional Studies",
            "Bias",
            "Acquired Immunodeficiency Syndrome"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40739213/",
        "source_type": "Global"
    },
    {
        "pmid": "40739198",
        "title": "Current state of medication treatment practice for heart failure with reduced ejection fraction among cardiologists in Japan: a survey on the relationship between satisfaction levels and adherence to guideline-directed medical therapy.",
        "abstract": "number patient heart failure steadily increasing parallel aging population Japan study aimed assess level satisfaction latest treatments identify factor influencing satisfaction investigate current guidelinedirected medical therapy GDMT practice heart failure reduced ejection fraction HFrEF among cardiologist Japan Respondents categorised two group based level satisfaction current treatment HFrEF responded 1 satisfied 2 Somewhat dissatisfied 3 Neither satisfied dissatisfied encompassed dissatisfied group Conversely responded 4 Somewhat satisfied 5 Satisfied comprised satisfied group total 203 valid response collected cardiologist Japan survey conducted December 27 2023 January 30 2024 respondent divided two group based satisfaction current HFrEF treatment dissatisfied n  92 satisfied n  111 demographic respondent two group revealed differences However dissatisfied group reported significantly higher proportion patient care considered refractory treatment satisfied group p  0015 Although dissatisfied group likely indicate patients heart failure HF underlying characteristic influenced treatment 415 vs 390 p  0045 satisfied group significantly likely indicate domestic 438 vs 413 p  0021 international 385 vs 360 p  0039 guideline influenced HF treatment practices Sodiumglucose transport protein 2 SGLT2 inhibitor prescription related increased satisfaction odds ratio 2199 95 confidence interval 11024392 p  0025 Approximately 50 respondent dissatisfied current pharmacological treatment patient chronic HFrEF suggesting SGLT2 inhibitor prescribed less frequently patient management tended guided individual symptom underlying HF characteristic rather strict adherence GDMT use SGLT2 inhibitor significantly associated higher treatment satisfaction particularly among physician adhered closely current GDMT recommendations",
        "mesh_terms": [
            "Humans",
            "Heart Failure",
            "Japan",
            "Stroke Volume",
            "Cardiologists",
            "Guideline Adherence",
            "Male",
            "Female",
            "Cardiovascular Agents",
            "Practice Patterns, Physicians'",
            "Practice Guidelines as Topic",
            "Middle Aged",
            "Health Care Surveys",
            "Ventricular Function, Left",
            "Attitude of Health Personnel",
            "Treatment Outcome"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40739198/",
        "source_type": "Global"
    },
    {
        "pmid": "40739178",
        "title": "Technology readiness among UK-based cognitively unaffected older adults during the COVID-19 pandemic: potential implications for decentralised alzheimer's disease prevention trials.",
        "abstract": "Alzheimers disease AD remains global health socioeconomic burden Telemedicine widely used since beginning COVID19 pandemic may effective strategy mitigate rising cost associated AD study aimed assess technology readiness among older adult risk developing dementia goal informing design delivery technologybased approach AD prevention research Cognitively unaffected older adult n  226 CHARIOT PRO Substudy invited complete CHARIOT Technology Questionnaire CTQ CTQ assessed technology experience attitudes including technology readiness via Technology Readiness Index TRI Female participant scored average lower TRI M  2750 SD  687 compared male M  2950 SD  602 Furthermore age predicted level technology readiness Exploratory factor analysis determined two factors Technology Competence Factor 1 Technology Trepidation Factor 2 Gender difference found Technology Competence but Technology Trepidation age predicted Technology Trepidation but Technology Competence Differences gender age Technology Competence Technology Trepidation may highlight need additional study andor support remotebased AD dementia prevention trials COVID19 accelerated adoption digitalisation AD dementia research deeper understanding barrier technology readiness may help inform future AD research studies CHARIOT PRO SubStudy registered clinicaltrialsgov NCT02114372",
        "mesh_terms": [
            "Humans",
            "Female",
            "COVID-19",
            "Male",
            "Alzheimer Disease",
            "Aged",
            "Telemedicine",
            "United Kingdom",
            "Aged, 80 and over",
            "Surveys and Questionnaires",
            "Pandemics",
            "SARS-CoV-2"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40739178/",
        "source_type": "Global"
    },
    {
        "pmid": "40736408",
        "title": "Breast Cancer Screening in Asian Countries: Epidemiology, Screening Practices, Outcomes, Challenges, and Future Directions.",
        "abstract": "2022 nearly 23 million new case breast cancer reported globally less half case originating Asia Despite relatively low incidence breast cancer part Asia mortalitytoincidence ratio remains high Lowincome country lack resource breast cancer screening whereas highincome country fail fully benefit national breast screening program underutilization preventive healthcare services notable difference age distribution breast cancer case Asian Western populations prevalence peaking approximately decade earlier Asian woman commonly affecting aged 4050 years Existing literature breast cancer trends screening guidelines clinical practice Asian countries particularly regarding regional variation healthcare system differences relatively sparse Gaining deeper understanding different Asian country implementing breast cancer screening response rising incidence disease help identify tailored strategy early detection ultimately contributing reduction breast cancerrelated mortality review explored current breast cancer landscape including breast cancer screening guideline outcome screening examination Asia highlighting key challenge future directions",
        "mesh_terms": [
            "Humans",
            "Breast Neoplasms",
            "Female",
            "Early Detection of Cancer",
            "Asia",
            "Mammography",
            "Incidence",
            "Mass Screening",
            "Middle Aged",
            "Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40736408/",
        "source_type": "Global"
    },
    {
        "pmid": "40735931",
        "title": "Exploration of the Optimal Treatment Modality for Vitreoretinal Lymphoma: A PRISMA Compliant Meta-Analysis and Systematic Review.",
        "abstract": "Vitreoretinal lymphoma VRL regarded subtype primary central nervous system lymphoma PCNSL Hence extending progressionfree survival PFS crucial enhancing prognosis VRL patients Nevertheless lack standard treatment option currently exists VRL systematic review aim explore optimal treatment strategy method systematic review metaanalysis adhered PRISMA guideline followed protocol registered PROSPERO registry search conducted PubMed Embase Scopus October 14 2023 using predefined search terms Primary endpoint included overall response rate ORR complete response rate CRR secondary endpoint comprised overall survival OS progressionfree survival PFS Thirtyseven study comprising 801 patient included metaanalysis pooled CRR 85 ORR 93 pooled 1year PFS 83 2year PFS 58 1year OS 92 2year OS 80 combined median PFS 2287 months median OS 5119 months Survival analysis extracted data showed significant association PFS OS systemic therapy p  000098 p  00091 multistrategy combination therapy p  00081 p  0007 however age gender bilateral involvement exhibited significant relationship p  005 conclusion existing treatment strategy led higher remission rate longer OS VRL patients PFS remains suboptimal primary focus future clinical basic research explore effective treatment strategy controlling disease recurrence progression metaanalysis registered international prospective register systematic review PROSPERO CRD42023400305",
        "mesh_terms": [
            "Humans",
            "Retinal Neoplasms",
            "Intraocular Lymphoma",
            "Lymphoma",
            "Treatment Outcome",
            "Progression-Free Survival",
            "Prognosis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40735931/",
        "source_type": "Global"
    },
    {
        "pmid": "40735894",
        "title": "Reviewing novel findings and advances in diagnoses and treatment of primary biliary cholangitis.",
        "abstract": "Primary biliary cholangitis PBC chronic autoimmune liver disease arises following progressive destruction intrahepatic bile ducts last decade growing incidence PBC registered worldwide compelling novel effective therapies review provides comprehensive update evolving landscape PBC management focus recent advance diagnosis treatment Diagnostic guideline major hepatology association emphasize importance antimitochondrial antibodies PBCspecific antinuclear antibodies liver biopsy select cases well emerging data highlight gammaglutamyl transferase prognostic marker firstline treatment remains ursodeoxycholic acid although least one third patient inadequate response 2024 authorization obeticholic acid farnesoid X receptor agonist previously approved 2016 revoked thus fibrates particularly bezafibrate considered secondline treatment improve biochemical marker potentially decrease longterm outcomes Alternative option agent targeting peroxisome proliferatoractivated receptors elafibranor seladelpar demonstrated efficacy clinical trials Novel approach managing symptom like fatigue pruritus also disposal Despite advances challenge remain optimizing care delivery developing treatment definitively alter disease progression",
        "mesh_terms": [
            "Humans",
            "Liver Cirrhosis, Biliary",
            "Ursodeoxycholic Acid",
            "Chenodeoxycholic Acid",
            "Cholagogues and Choleretics",
            "Treatment Outcome",
            "Biomarkers",
            "Fibric Acids",
            "Predictive Value of Tests"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40735894/",
        "source_type": "Global"
    },
    {
        "pmid": "40735539",
        "title": "Bone shape changes over two years following acute anterior cruciate ligament injury: Reconstructed vs non-reconstructed knees.",
        "abstract": "determine bone shape change two year acute anterior cruciate ligament ACL injury compare knee treated ACL reconstruction ACLR v ACLR used prospective data involving 129 young adult 46 ​ female mean age 25 years recent ACL injury subcohort within prospective multicenter NACOX study Patients treated according Swedish guideline supervised rehabilitation considering ACLR 3D MR image obtained baseline 3 6 12 24months postinjury assessed change femur tibia bone surface area using active appearance models used linear mixedeffects model adjusted age sex body mass index preinjury Tegner physical activity level observed growth bone area first two years particularly medial femur medial tibia average relative increase 128 ​ 95 ​ CI 067 ​ 188 ​ 104 ​ 044 ​ 165 ​ respectively lateral femur also showed growth increase 115 ​ 055 ​ 175 ​ found little difference comparing ACLR patient nonACLR patients adjusted relative percentage differences medial femur 001 ​ 95 ​ CI 09 ​ 11 ​ medial tibia 003 ​ 12 ​ 07 ​ lateral femur 004 ​ 06 ​ 14 ​ lateral tibia 011 ​ 21 ​ 01 ​ acute ACL injury growth primarily medial femoral tibial condyles bone shape change could hypothetically response altered biomechanical condition may precede development knee OA",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40735539/",
        "source_type": "Global"
    },
    {
        "pmid": "40733123",
        "title": "Pharmacokinetics of Pegaspargase with a Limited Sampling Strategy for Asparaginase Activity Monitoring in Children with Acute Lymphoblastic Leukemia.",
        "abstract": "bBackgroundb Asparaginase ASPase play important role therapy acute lymphoblastic leukemia ALL Serum ASPase activity SAA modified even abolished host immune responses therefore current treatment guideline recommend monitor SAA treatment administration SAA monitoring schedule need carefully planned reduce number sample without hampering possibility measuring pharmacokinetics PK parameter individual patients Complex modelling approaches easily applicable common practice applied previous study estimate ASPase PK parameters study aimed estimate PK parameter using simplified approach suitable realworld setting limited sampling bMethodsb study based 434 patient treated Italy within AIEOPBFM 2009 trial induction phase patient received two dos pegylated ASPase monitored blood sampling five time points including time 0 PK parameter estimated using individually available SAA measurement simple modification classical noncompartmental PK analysis also took opportunity develop validate series limited sampling model predict ASPase exposure bResultsb induction phase average ASPase activity day 7 1380 IUL first dose 1948 IUL second dose therapeutic SAA level 100 IUL maintained day 33 901 patients average AUC clearance 46937 IUL × day 0114 Ldaymsup2sup respectively database analyzed possible association PK parameter biological characteristic patients finding limited dependence sex age risk score however difference sufficient allow dose schedule adjustments Thereafter possibility sampling reduction using simple linear model estimate AUC also explored simple model required two sampling 7 day ASPase dose AUC proportional sum two measured activity A7 A21 calculated formula AUC  141 × A7  A21 model predicts AUC 6 average error 35 maximum error compared AUC estimated available measures bConclusionsb study demonstrates feasibility direct estimation PK parameter reallife situation limited variable blood sampling schedule also offer simplified method formula easily applicable clinical practice maintaining reliable pharmacokinetic monitoring",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40733123/",
        "source_type": "Global"
    },
    {
        "pmid": "40731388",
        "title": "Association between perceived neighborhood environment, sedentary behavior, walking, and moderate-to-vigorous physical activity and frailty: an isotemporal substitution model.",
        "abstract": "rapid increase older population growing demand longevity worldwide frailty become major hurdle sustaining healthy aging residential area primary domain mobility older adults neighborhood environment crucial factor daily living physical activity study aim investigate whether replacing sedentary behavior physical activity supportive neighborhood environment associated frailty status older adults crosssectional analysis conducted 2650 participant aged 7084 year Korean Frailty Aging Cohort Study KFACS main explanatory variable included selfreported physical activity sedentary behavior SB perceived neighborhood environment Frailty response variable defined using Fried frailty phenotype Multinomial regression performed analyze outcome Isotemporal Substitution Model ISM applied examine effect replacing sedentary behavior physical activity frailty status participant categorized 453 robust 473 prefrail 76 frail Accessibility factor associated decreased risk prefrail odds ratio OR 0750 95 CI 06730836 frail OR 0654 95 CI 05410789 compared robust According ISM substituting 10 min SB type physical activity associated reduced risk prefrailty if 10 min SB replaced 10 min walking OR 0972 CI 09600985 frailty if 10 min SB replaced MVPA OR 0877 CI 08360921 walking OR 0852 CI 08140891 Replacing SB walking improving neighborhood accessibility significantly associated reduced risk prefrail frail finding highlight importance considering factor designing agefriendly environment older adults",
        "mesh_terms": [
            "Humans",
            "Male",
            "Cross-Sectional Studies",
            "Female",
            "Aged",
            "Sedentary Behavior",
            "Aged, 80 and over",
            "Frailty",
            "Exercise",
            "Walking",
            "Neighborhood Characteristics",
            "Residence Characteristics",
            "Republic of Korea",
            "Frail Elderly",
            "Cohort Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40731388/",
        "source_type": "Global"
    },
    {
        "pmid": "40731350",
        "title": "Advancing equity in cervical cancer screening for sexual and gender minoritized people assigned female at birth (SGM AFAB) in the United States: recommendations from healthcare equity leaders.",
        "abstract": "Sexual gender minoritized SGM people including limited lesbian gay bisexual transgender queer LGBTQ people assigned female birth AFAB experience greater burden cervical cancer relative heterosexual cisgender counterparts However face pronounced systemic barrier regular cervical cancer screening Although evidencebased clinical guideline play integral role implementation preventive measures existing United States US cervical cancer screening guideline consider specific experiences needs context SGM AFAB people concerning cervical cancer outcome cervical cancer screening Thus imperative determine cervical cancer screening guideline revised better address unique specific cervical cancer prevention need SGM AFAB people US conducted virtual key informant interview elicit recommendation advancing SGM health equity developing implementing cervical cancer screening guideline healthcare equity leader N  18 including half expertise SGM AFAB peoples healthcare Interviews analyzed using templatestyle thematic analysis approach develop theme subthemes Healthcare equity leader provided three key recommendation advancing SGM health equity development implementation US cervical cancer screening guidelines Healthcare equity leader recommended prioritizing community personcentered strategies including engaging SGM community development guideline using SGMaffirming approach implementation Revising language reproduces harmful normative exclusionary assumption gender sexuality context cervical cancer screening guideline also recommended Lastly leader recommended range strategy mitigate systemic barrier cervical cancer screening among SGM AFAB people including collecting utilizing representative data SGM AFAB peoples needs experiences context develop guideline ensure cultural responsiveness delivery cervical cancer screening SGM AFAB people across healthcare systems studys finding contribute improving advancing health equity cervical cancer screening SGM AFAB population communitycentered development inclusive evidencebased guideline personcentered implementation clinical settings",
        "mesh_terms": [
            "Humans",
            "Uterine Cervical Neoplasms",
            "Female",
            "Early Detection of Cancer",
            "United States",
            "Sexual and Gender Minorities",
            "Health Equity",
            "Male",
            "Adult",
            "Practice Guidelines as Topic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40731350/",
        "source_type": "Global"
    },
    {
        "pmid": "40725984",
        "title": "The APLAR Recommendations for the Management of Psoriatic Arthritis.",
        "abstract": "auspex AsiaPacific League Associations Rheumatology APLAR aimed develop broad evidence consensusbased guideline aid health professional managing patient psoriatic arthritis PsA region working group 35 member comprising rheumatologists dermatologists patient research partner 18 APLAR country convened working group conducted systematic literature review derive quality evidence via GRADE method supporting efficacy safety class therapeutic agent management active PsA comorbidities screening specific infection concern region Recommendation statement principle management best use therapeutic drug developed Consensus within working group achieved external voting panel five 18 APLAR countries convened confirm agreement recommendation statements main literature review included 178 article clinical trial PsA Additional article evidence managing comorbidities uveitis inflammatory bowel disease screening chronic hepatitis B latent tuberculosis reviewed working group discussed reached consensus eight management principle 16 recommendation statement managing PsA Endorsement external voting panel n  90 response rate 80 achieved first recommendation management PsA patient APLAR region developed based best available evidence regionspecific consideration discussion among rheumatologists dermatologists patients strong agreement external expert panel",
        "mesh_terms": [
            "Humans",
            "Antirheumatic Agents",
            "Arthritis, Psoriatic",
            "Comorbidity",
            "Consensus",
            "Evidence-Based Medicine",
            "Rheumatology",
            "Treatment Outcome",
            "Systematic Reviews as Topic"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40725984/",
        "source_type": "Global"
    },
    {
        "pmid": "40722080",
        "title": "Comparison of SPEED and OSDI questionnaires for dry eye symptom in Chinese college students: a cross-sectional study.",
        "abstract": "compare suitability Standard Patient Evaluation Eye Dryness SPEED Ocular Surface Disease Index OSDI among Chinese college students validate SPEED questionnaire using OSDI nonclinical sample crosssectional study involved 1084 student Nanyang Medical College aged 18 21 years student completed OSDI SPEED questionnaire assess dry eye symptoms correlation score two questionnaire analyzed assess criterion validity Based OSDI scores receiver operating characteristic curve constructed determine area ROC curve cutoff point evaluating diagnostic threshold SPEED questionnaire Cronbachs alpha value OSDI SPEED questionnaire 0943 0911 respectively Notably 281 participant 2592 completed 12 question OSDI questionnaire whereas participant completed SPEED questionnaire without omitting questions mean SPEED score Full 371 1157 1384 1972 subgroup Posthoc testing revealed statistically significant difference group P  005 significant correlation observed OSDI score SPEED score SPEED score Full particularly SPEED score SPEED score Full comparison OSDI questionnaire SPEED questionnaire demonstrates favorable response rate reliability validity differentiating dry eye symptom among Chinese college students may appropriate diagnosing dry eye conducting epidemiological study within population",
        "mesh_terms": [
            "Humans",
            "Cross-Sectional Studies",
            "Dry Eye Syndromes",
            "Male",
            "Female",
            "Surveys and Questionnaires",
            "Young Adult",
            "Adolescent",
            "China",
            "Students",
            "ROC Curve",
            "Reproducibility of Results",
            "Universities"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40722080/",
        "source_type": "Global"
    },
    {
        "pmid": "40722071",
        "title": "HIV/AIDS-related stigma and discrimination among healthcare providers in Western China: a population-based cross-sectional study.",
        "abstract": "persistence Human Immunodeficiency Virus HIV andor Acquired Immune Deficiency Syndrome AIDSrelated stigma discrimination healthcare setting remains critical issue urgently requires attention effectively control HIVAIDS epidemic study aimed evaluate extent HIVAIDSrelated stigma discrimination explore influencing factor among healthcare provider western China order inform decisionmaking regarding reduction stigma discrimination intervention crosssectional study conducted October 2023 July 2024 24646 with response rate 986 healthcare provider completed survey using concise standardized instrument including sociodemographic workrelated characteristics healthcare institutional policy guidelines attitude opinion people living Human Immunodeficiency Virus PLHIV well discriminatory behaviors Multivariate linear regression analysis performed assess influencing factor HIVAIDSrelated stigma discrimination among healthcare providers proportion healthcare provider expressing concern dressing wound drawing blood 651 603 respectively Approximately 40 participant believed PLHIV care infected others multiple sexual partners Healthcare provider experienced secondary stigma discrimination provision service PLHIV direct stigma discrimination PLHIV 671 respondent agreed PLHIV allowed baby wish 7198 indicated institution related policy guideline protect HIVAIDS patient discrimination HIVAIDSrelated discriminatory behavior higher among healthcare provider lower level education training worked private infectious disease hospital hospital inadequate policies provided face face service PLHIV higher level stigmatizing attitude P  005 HIVAIDSrelated stigma discrimination among healthcare provider prevalent western China factor identified study associated higher HIVAIDSrelated stigma discrimination may provide valuable insight mitigating negative associations coordinated multifaceted approach intervention need implemented effectively reduce HIVAIDSrelated stigma discrimination healthcare settings",
        "mesh_terms": [
            "Humans",
            "Cross-Sectional Studies",
            "China",
            "Male",
            "Social Stigma",
            "Female",
            "Adult",
            "Health Personnel",
            "HIV Infections",
            "Middle Aged",
            "Attitude of Health Personnel",
            "Surveys and Questionnaires",
            "Acquired Immunodeficiency Syndrome",
            "Young Adult",
            "Social Discrimination"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40722071/",
        "source_type": "Global"
    },
    {
        "pmid": "40720465",
        "title": "Prevalence of genetic variants in SERPINB2 and PKNOX1 genes in erythema nodosum leprosum patients from southern Brazil.",
        "abstract": "Erythema nodosum leprosum ENL humoral immune response Mycobacterium leprae characterized erythematous nodules may may associated systemic symptoms Thalidomide primary treatment ENL Brazil peripheral neuropathy PN significant adverse effect Genetic variant SERPINB2 PKNOX1 gene implicated predisposition develop thalidomideinduced peripheral neuropathy TiPN patient multiple myeloma study evaluated prevalence polymorphism SERPINB2 PKNOX1 ENL patients crosssectional study conducted sample ENL patient southern Brazil assess presence genetic variant SERPINB2 PKNOX1 Fortyseven patient ENL included prevalence SERPINB2 rs6103 66 C allele 34 G allele prevalence PKNOX1 rs2839629 75 allele 25 G allele significantly relevant presence PKNOX1 rs2839629 allele patient ENL p  0001 case patient PN presence C genotype rs6103 SERPINB2 85 homozygosity 773 heterozygosity presence genotype rs2839629 PKNOX1 84 homozygosity 80 heterozygosity Polymorphisms SERPINB2 PKNOX1 identified patient ENL emphasis PKNOX1 confirmed robust future studies finding may guide clinical decision treatment guideline ENL",
        "mesh_terms": [
            "Humans",
            "Brazil",
            "Male",
            "Female",
            "Cross-Sectional Studies",
            "Adult",
            "Middle Aged",
            "Erythema Nodosum",
            "Prevalence",
            "Young Adult",
            "Genetic Predisposition to Disease",
            "Leprosy, Lepromatous",
            "Aged",
            "Genotype",
            "Polymorphism, Single Nucleotide"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40720465/",
        "source_type": "Global"
    },
    {
        "pmid": "40720186",
        "title": "`Resigned agency' in older adults: a meta-ethnography of the lived experience of urinary incontinence.",
        "abstract": "Urinary incontinence UI highly prevalent among older adult often lead significant physical social psychological consequences Understanding lived experience essential developing effective personcentred intervention address physiological also emotional social dimension UI qualitative systematic review following PRISMA guideline conducted identify original study explored older adults experience UI Databases including PubMed EMBASE Scopus PsycINFO searched 30 November 2024 Eligible study employed qualitative method mixedmethods design clear qualitative component examined participant aged 60 older type UI focused perceptions coping mechanism lived experiences Metaethnography guided synthesis first second thirdorder constructs Thirtytwo study included Five interlinked theme emerged i normalisation UI part ageing ii stigma concealment iii adaptive selfmanagement strategies iv barrier critical trigger helpseeking v identity disruption relational strain central concept resigned agency identified individual acknowledged burden UI yet deferred helpseeking navigating condition selfregulation quiet endurance Older adult UI often enact form resigned agency balancing silent acceptance personal coping strategy delaying avoiding formal care future work intervention such destigmatising conversation support developed address individual illness representation social context shape them including stigma cultural norm healthcare responsiveness study protocol registered PROSPERO registration number CRD42024614673",
        "mesh_terms": [
            "Humans",
            "Urinary Incontinence",
            "Aged",
            "Adaptation, Psychological",
            "Anthropology, Cultural",
            "Qualitative Research",
            "Female",
            "Social Stigma",
            "Male",
            "Middle Aged",
            "Aging",
            "Self-Management",
            "Aged, 80 and over"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40720186/",
        "source_type": "Global"
    },
    {
        "pmid": "40719431",
        "title": "Surgical treatment and locoregional therapy of liver metastases from pancreatic ductal adenocarcinoma: review of current strategies.",
        "abstract": "Pancreatic ductal adenocarcinoma PDAC one lethal cancer 5year survival 810 Approximately 50 case present metastasis time diagnosis liver representing common site International guideline recommend palliative chemotherapy metastatic disease yet several study report prolonged survival surgery locoregional therapy selected patient synchronous metachronous liver metastasis LM Despite numerous attempt define selection criterion patient LM PDAC would benefit surgery evidence contradictory article aim describe underlying principle paradigm shift multimodal management hepatic oligometastatic PDAC providing summary published series respect morbidity mortality survival outcomes Upfront resection primary tumor synchronous LM avoided since imply prolonged survival compared patient liver oligometastatic PDAC candidate chemotherapy Resection radiofrequency ablation metachronous liver lesion option case small metastasis amenable minor resection Management liver oligometastatic PDAC neoadjuvant therapy performed case good response chemotherapy accurate restaging Yet duration neoadjuvant therapy entity biological response issue still undefined setting Ongoing trial may overcome limitation retrospective studies well molecular biology help better understand tumor behavior tailor surgical approach cancer genetic signature",
        "mesh_terms": [
            "Humans",
            "Liver Neoplasms",
            "Pancreatic Neoplasms",
            "Carcinoma, Pancreatic Ductal",
            "Neoadjuvant Therapy",
            "Combined Modality Therapy",
            "Radiofrequency Ablation",
            "Hepatectomy"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40719431/",
        "source_type": "Global"
    },
    {
        "pmid": "40715509",
        "title": "Sintilimab plus lenvatinib in combination with transarterial chemoembolization and subsequent radiofrequency ablation for unresectable hepatocellular carcinoma: a single-arm, single-center study.",
        "abstract": "study designed assess safety efficacy Sintilimab plus Lenvatinib combination transarterial chemoembolization TACE subsequent radiofrequency ablation RFA treatment unresectable hepatocellular carcinoma HCC retrospective data analysis conducted 21 patient diagnosed HCC Yibin First Peoples Hospital February 2021 July 2022 patient met eligibility criterion underwent TACE followed RFA first TACE patient received maintenance therapy Sintilimab Lenvatinib occurrence intolerable toxicity disease progression demise primary endpoint progressionfree survival PFS overall survival OS efficacy evaluation revealed complete response CR 7 patient 3333 partial response PR 13 6191 stable disease SD 1 476 patient median followup duration 294 month 95 CI 24673414 median PFS 173 month 95 CI 5842876 median OS reached NR 1year OS rate 9524 2year OS rate 7589 Tumor recurrence metastasis occurred 15 patient 7143 oligoprogression 8 patient 3890 extensive progression 7 patient 3333 associated median OS duration NR 2603 month 95CI 17483459 respectively P  0024 term treatment safety 9524 20 cases patient experienced treatmentrelated adverse event AEs mainly mild moderate severity Notably 10 patient 4762 encountered least one grade 3 higher AEs leading treatment discontinuation 2 patient due severe side effects clinical efficacy safety Sintilimab plus Lenvatinib combination TACE followed RFA shown promising treatment unresectable HCC result suggested combined treatment strategy may effective therapeutic approach Furthermore patient oligoprogression initial treatment exhibited favorable prognosis indicating need exploration validation study larger sample sizes",
        "mesh_terms": [
            "Humans",
            "Carcinoma, Hepatocellular",
            "Liver Neoplasms",
            "Male",
            "Female",
            "Chemoembolization, Therapeutic",
            "Middle Aged",
            "Aged",
            "Quinolines",
            "Radiofrequency Ablation",
            "Phenylurea Compounds",
            "Antibodies, Monoclonal, Humanized",
            "Retrospective Studies",
            "Combined Modality Therapy",
            "Treatment Outcome",
            "Antineoplastic Combined Chemotherapy Protocols",
            "Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40715509/",
        "source_type": "Global"
    },
    {
        "pmid": "40715499",
        "title": "Exploration of potential therapeutic target genes for preeclampsia through genetic analysis.",
        "abstract": "Preeclampsia PE prevalent severe pregnancyrelated complication effective intervention target remain limited posing significant risk maternal fetal health study aimed identify potential therapeutic target gene genetic analyses Specifically utilized cisexpression quantitative trait locus ciseQTL druggable gene derived blood sample obtained eQTLGen consortium exposure data Subsequently Mendelian randomization MR analysis conducted explore causal association druggable gene PE Functional enrichment analysis Summarydatabased MR SMR colocalization analysis employed validate identified genes MR result revealed 17 druggable gene significantly associated PE multiple testing correction FDR  005 Functional enrichment analysis indicated gene involved key biological process leukocyte proliferation activation immune response regulation metabolism watersoluble vitamins Additionally found participate several critical signaling pathways including complement coagulation cascades reninangiotensin system folate biosynthesis SMR colocalization analysis confirmed causal relationship PE five genesTESK2 LNPEP CD320 NELL2 SF3B3 Moreover singlecell RNA sequencing data supported association expression level TESK2 CD320 SF3B3 development PE study provides preliminary evidence identifying several potential genetic target may help reduce risk PE genomic perspective finding offer novel scientific insight research direction future drug development optimization therapeutic strategy aimed managing preventing PE",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40715499/",
        "source_type": "Global"
    },
    {
        "pmid": "40714729",
        "title": "Post COVID 19 resurgence of diphtheria in Kano, Nigeria: analysis of 18,320 cases.",
        "abstract": "COVID 19 pandemic led significant disruption health services including immunisation programs contributed major postpandemic diphtheria outbreak Kano State Nigeria region accounted 85 nations documented diphtheria cases study examined epidemiology clinical characteristics mortality outcome case diagnosed February 2022 April 2024 Data collected Surveillance Outbreak Response Management Analysis System SORMAS case definition followed guidelines Case fatality rate CFR calculated logistic regression model used assess mortalityrelated risk factors reporting adjusted odds ratio AOR total 18320 case analysed outbreak showing bimodal distribution primary peak occurred August 2023 followed smaller secondary peak early 2024 case fatality rate CFR 45 Patients vaccinated double likelihood death compared fully vaccinated individual AOR 245 95 CI 205 294 p  00001 logistic regression Similarly patient without vaccination documentation also greater odds 87 increase likelihood mortality compared fully vaccinated individual AOR 187 95 CI 127 268 p  00001 logistic regression study reinforces previous report weakening preventive health delivery system resource constrained settings particularly disruption caused COVID 19 pandemic leading resurgence vaccine preventable diseases diphtheria highlight need improved vaccination coverage surveillance systems research receive external funding",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40714729/",
        "source_type": "Global"
    },
    {
        "pmid": "40713827",
        "title": "Iparomlimab and tuvonralimab (QL1706) plus chemotherapy and bevacizumab for EGFR-mutant patients with advanced non-small cell lung cancer after failure of EGFR-tyrosine kinase inhibitors: updated results from cohort 5 in the DUBHE-L-201 study.",
        "abstract": "Iparomlimab tuvonralimab QL1706 bifunctional antiprogrammed death1cytotoxic Tlymphocyte antigen4 antibody combination bevacizumab doublet chemotherapy tolerable showed preliminary antitumor activity advanced nonsmall cell lung cancer NSCLC DUBHEL201 study Here report updated data longterm survival prognosis safety cohort 5 Epidermal growth factor receptor EGFRmutant patient progressed EGFRtyrosine kinase inhibitor TKIs enrolled cohort 5 received QL1706 5 mgkg combined bevacizumab pemetrexed carboplatin threeweek cycle four cycle followed maintenance therapy QL1706 bevacizumab pemetrexed Survival outcome adverse event followed up July 5 2024 median duration response progressionfree survival PFS overall survival OS 31 patient cohort 5 1133 month 95 confidence interval CI 4171991 851 month 95 CI 5721331 2651 month 95 CI 1281not reached respectively 23 742 patient received subsequent anticancer therapy disease progression median PFS 1002 months median PFS 851 month vs 595 months P  0622 median OS 3019 month vs 1068 months P  0177 appeared longer patient 21L858R mutation compared 19Del although difference statistically significant Grade ≥ 3 treatmentrelated adverse event occurred 13 419 patients Nineteen 613 patient immunerelated adverse events one 32 grade ≥ 3 new safety signal observed QL1706 combining pemetrexed carboplatin bevacizumab showed longterm favorable prognosis manageable safety profile advanced EGFRmutant patient NSCLC failure EGFRTKIs",
        "mesh_terms": [
            "Adult",
            "Aged",
            "Female",
            "Humans",
            "Male",
            "Middle Aged",
            "Antibodies, Bispecific",
            "Antibodies, Monoclonal, Humanized",
            "Antineoplastic Combined Chemotherapy Protocols",
            "Bevacizumab",
            "Carcinoma, Non-Small-Cell Lung",
            "Cohort Studies",
            "ErbB Receptors",
            "Lung Neoplasms",
            "Mutation",
            "Pemetrexed",
            "Protein Kinase Inhibitors",
            "Tyrosine Kinase Inhibitors"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40713827/",
        "source_type": "Global"
    },
    {
        "pmid": "40713520",
        "title": "Prior antiretroviral therapy exposure among clients presenting for HIV treatment initiation in South Africa: an exploratory mixed-methods study using multiple indicators of exposure.",
        "abstract": "era universal treatment HIV seen high rate disengagement antiretroviral therapy ART program reengagement interruptions modeled estimate nonnaïve initiator  50 many places reengagers reluctant admit prior antiretroviral exposure nonselfreported data proportion reinitiating scarce conducted sequential mixedmethods study explore proportion people present initiation evidence prior ART use understand many reluctant admit prior exposure South Africa enrolled sequential sample adult presenting initiate ART reinitiate ART interruption  3 month collected 1 selfreported previous treatment experience 2 electronic medical record EMR evidence prior ART clinic visits 3 baseline blood test metabolite tenofovir diphosphate 4 laboratory record indicating prior ARTrelated tests Interviews conducted client selfreported prior ART use evidence metabolites Among 89 enrolled participant median age 325 62 female 21 24 selfreported previously taking ART  3 month prior enrolment additional 19 21 selfreport prior exposure EMR laboratory evidence prior ART use total 40 45 client known prior treatment exposure initiation Sensitivity selfreport 40 95 CI 2557 EMR 43 2759 metabolite testing 45 2962 laboratory record 73 5687 Interviewees n  11 reported opting present naïve perceived disclosure prior disengagement would cause delay accessing treatment require additional documentation elicit negative response healthcare workers Study limitation included short duration metabolite detectability inability link individual within EMR discern ART experience facilities lack baseline viral load testing least 45 client initiating ART South Africa prior treatment experience third reinitiators voluntarily reveal this Laboratory record yielded accurate result ascertaining prior treatment exposure number reengaging HIV care treatment interruption increase understanding reluctance selfreport ART experience exploring opportunity overcome barrier critical preventing repeated interruptions protocol registered July 12 2022 clinicaltrialsgov NCT05454839",
        "mesh_terms": [
            "Adult",
            "Female",
            "Humans",
            "Male",
            "Middle Aged",
            "Young Adult",
            "Anti-HIV Agents",
            "HIV Infections",
            "South Africa",
            "Tenofovir"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40713520/",
        "source_type": "Global"
    },
    {
        "pmid": "40713084",
        "title": "Cross-national research on adolescent mental health: a systematic review comparing research in low, middle and high-income countries.",
        "abstract": "Although 90 global adolescent population resides low middleincome country LMICs crossnational mental health research primarily focused highincome countries systematic review aim examine crossnational studies including LMICs focusing adolescent mental health psychosocial problems Peerreviewed article comparing adolescent mental health psychosocial issue across country included published English based observational study designs Six database searched inception January 2024 Risk bias assessed using JBI tool additional crossnational quality criteria narrative synthesis conducted following Synthesis Without Metaanalysis guidelines search identified 172 study including data 12 million adolescent across 166 countries used international survey Health Behaviour Schoolaged Children study study employed crosssectional design schoolbased selfreported questionnaires Adolescent mental health research involved 166 countries 52 country represented studies inclusion LMICs crossnational research increased time Internalising problem bullying wellresearched topics study externalising behaviour limited number publication increased time particularly 2020 Variations income level observed traditional bullying prevalent LMICs review provides important insight global pattern gap adolescent mental health research highlight need address methodological heterogeneity including use validated culturally adapted measures comprehensive reporting sampling procedures sample sizes response rate greater attention generalisability addition targeted inclusion underrepresented region essential addressing global disparity informing effective interventions CRD42024505077",
        "mesh_terms": [
            "Humans",
            "Adolescent",
            "Mental Health",
            "Developing Countries",
            "Developed Countries",
            "Adolescent Health"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40713084/",
        "source_type": "Global"
    },
    {
        "pmid": "40712559",
        "title": "Carcinoembryonic antigen as a predictor of treatment outcomes in cancer patients receiving immune checkpoint inhibitors.",
        "abstract": "Carcinoembryonic antigen CEA widely used tumor marker associated traditional therapeutic efficacy study aim assess predictive significance baseline carcinoembryonic antigen CEA level CEA level change efficacy immune checkpoint inhibitor ICIs cancer patients systemic literature search conducted three digital repositoriesEmbase PubMed Cochrane Libraryto obtain study linking CEA clinical result cancer patient receiving ICIs year inception database 20 August 2024 Studies included involved cancer patient treated ICIs assessed prognostic significance baseline CEA level CEA level changes reported least one outcome metric including overall survival OS progressionfree survival PFS disease control rate DCR pathological complete response pCR objective response rate ORR Duplicate study identified removed using Covidence software following Cochrane collaboration guidelines NewcastleOttawa Scale applied evaluate study quality Pooled hazard ratio HRs OS PFS well odds ratio ORs DCR pCR ORR calculated 95 confidence interval CIs analysis included 27 studies comprising total cohort 3662 patients finding revealed cancer patient receiving ICIs lower CEA level significantly improved OS HR 184 ipi  0001 PFS HR 164 ipi  0001 along higher DCR OR 181 ipi  0001 ORR OR 053 ipi  0001 pCR OR 058 ipi  0001 compared elevated CEA levels Additionally reduction CEA level immunotherapy significantly associated prolonged OS HR 0507 ipi  0001 PFS HR 0501 ipi  0001 well increased ORR OR 239 ipi  0005 DCR OR 294 ipi  0001 result advocate integrating CEA level assessment prognostic analysis cancer patients",
        "mesh_terms": [
            "Humans",
            "Carcinoembryonic Antigen",
            "Immune Checkpoint Inhibitors",
            "Neoplasms",
            "Treatment Outcome",
            "Biomarkers, Tumor",
            "Prognosis",
            "Progression-Free Survival"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40712559/",
        "source_type": "Global"
    },
    {
        "pmid": "40708026",
        "title": "Japanese experience of newborn screening for lysosomal storage diseases and adrenoleukodystrophy.",
        "abstract": "Recently Newborn screening NBS expanded worldwide include lysosomal storage disease LSDs adrenoleukodystrophy ALD due importance early diagnosis early treatment Japan NBS LSDs termed expanded NBS first implemented Kumamoto prefecture 2006 pilot study NBS ALD subsequently introduced Aichi prefecture Gifu prefecture 2021 Expanded NBS LSDs ALD become widespread Japan light current situation considered necessary clarify usefulness expanded NBS prevalence disease challenge encountered Therefore reported current implementation status expanded NBS Japan survey conducted among physician responsible expanded NBS target region Japan target region implemented NBS LSDs andor ALD one year survey item included entity conducting expanded NBS facility conducting tests target areas medical institution close examination detailed biochemical analysis andor genetic sequencing treatments type target diseases fee NBS sample collection methods testing method quantitative data expanded NBS retesting diagnosis area Responses received nine region organization CReARID total number 733838 newborn screening 101 diagnoses 75 case Fabry disease 10 mucopolysaccharidosis MPS II 8 Pompe disease 5 Gaucher disease 2 MPS I 1 ALD respectively diagnosed case diagnosed target disease estimated prevalence contrast positive predictive value low falsepositive rate elevated particularly PD MPS II ALD attributed pseudodeficiency allele methodological differences Moreover variant unknown significance VUS ABCD1 gene detected many patient suspected ALD Japan Expanded NBS LSDs ALD become widespread Since implementation patient diagnosed received treatment However challenge pseudodeficiency indications testing methods VUS require improvement",
        "mesh_terms": [
            "Humans",
            "Lysosomal Storage Diseases",
            "Neonatal Screening",
            "Infant, Newborn",
            "Adrenoleukodystrophy",
            "Japan",
            "East Asian People"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40708026/",
        "source_type": "Global"
    },
    {
        "pmid": "40704853",
        "title": "Real-world use of biologic and targeted synthetic disease-modifying antirheumatic drugs in US patients with psoriatic arthritis: Persistence, patient characteristics associated with discontinuation, and dosing patterns.",
        "abstract": "Psoriatic arthritis PsA chronic immunemediated inflammatory arthropathy presenting multiple manifestations including peripheral arthritis enthesitis skin psoriasis PSO Immunosuppressiveimmunomodulatory therapies including biologictargeted synthetic diseasemodifying antirheumatic drug btsDMARD common effective treatment PsA however discontinuation reported contributing factor remain unclear describe probability persistence time discontinuation including switch btsDMARD therapy btsDMARDnaive experienced patient PsA within 12 month following initiation new btsDMARD Secondary objective included 1 describing factor associated btsDMARD persistence nonpersistence 2 assessing maintenance dose change among patient PsA initiating antiIL17A agent secukinumab SEC ixekizumab IXE SEC IXE particular focus owing variability dosage recommendation guideline time study observational cohort study used Merative MarketScan data included patient initiating new prescription btsDMARD treatment PsA diagnosis PsA January 1 2017 June 30 2021 primary outcome persistence defined day btsDMARD therapy use index date 12 month continuous index treatment first occurrence btsDMARD discontinuationswitch Associations patient characteristic outcome explored using Cox regressions descriptive dose analysis exploring proportion patient specific startingmaintenance btsDMARD doses 7037 adult patient PsA included 267 PsA 733 PsAPSO baseline 12month probability persistence btsDMARD treatment 512 95 CI 495529 83month mean length persistence Treatment persistence probability 12 month 527 508577 patient PsAPSO 470 437503 patient PsA only Treatment persistence probability 12 month 514 496532 btsDMARDnaive subgroup 498 455541 btsDMARDexperienced group Female sex baseline codiagnosis fatigue associated increased probability nonpersistence whereas codiagnosis PSO associated decreased probability nonpersistence dosing analysis patient initiating SEC therapy included analysis 604 prescribed starting maintenance dose 300 mg every 4 week Q4W 341 prescribed starting maintenance dose 150 mg Q4W patient initiating IXE therapy included analysis 844 prescribed 80mg Q4W starting maintenance dose 104 prescribed 160mg Q4W starting maintenance dose finding study provide relevant insight tailoring btsDMARD therapy maximize clinical benefit potentially identify patient greatest unmet need",
        "mesh_terms": [
            "Humans",
            "Arthritis, Psoriatic",
            "Male",
            "Female",
            "Middle Aged",
            "Antirheumatic Agents",
            "Adult",
            "United States",
            "Antibodies, Monoclonal, Humanized",
            "Biological Products",
            "Cohort Studies",
            "Dose-Response Relationship, Drug",
            "Aged",
            "Retrospective Studies"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40704853/",
        "source_type": "Global"
    },
    {
        "pmid": "40703469",
        "title": "Reporting Guidelines for Community Outbreak Investigation Reporting (G-CORE): protocol for guideline development.",
        "abstract": "bObjectivesb Outbreak report essential documenting spread response disease outbreaks However lack standardized reporting guideline encompass broader perspective outbreaks aimed develop universal reporting guideline applicable diverse outbreak report community epidemic interventions Guidelines Community Outbreak Investigation Reporting GCORE bMethodsb GCORE designed address challenge documenting various outbreak scenarios including infectious disease noninfectious environmental hazards development GCORE involved structured process including comprehensive literature review recent outbreak report leading journal analysis existing reporting guidelines process also involved project registration EQUATOR Network collaboration expert various fields Following initial drafting internal team review conducted evaluate guidelines robustness relevance Subsequently guideline underwent revision based feedback external expert potential users including author experience outbreak reporting project also includes plan widespread dissemination periodic revision adapt development user feedback bResultsb GCORE provide structured framework reporting outbreak investigations comprising detailed checklist Explanation  Elaboration documents bConclusionb GCORE establishes new standard outbreak reporting facilitating comprehensive clear actionable public health communications development mark significant advance documentation management public health outbreaks",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40703469/",
        "source_type": "Global"
    },
    {
        "pmid": "40702551",
        "title": "Survival in patients with unresectable hepatocellular carcinoma: TCC cocktail plus TACE vs TACE alone prospective randomized clinical trial.",
        "abstract": "Transarterial chemoembolization TACE commonly used treat patient unresectable hepatocellular carcinoma HCC however TACE alone demonstrated unsatisfactory survival benefits previous study suggested TACE plus oral medication thalidomide carmofur compound mylabris capsule TCC cocktail may better therapeutic option randomized openlabel multicenter clinical trial 72 treatmentnaive HCC patient randomly assigned receive cTACE alone cTACE plus oral TCC cocktail July 2018 October 2019 primary endpoint trial 1 2 3year overall survival OS rates second endpoint trial included 1 2 3year progressionfree survival PFS rates objective response rate ORR according modified Response Evaluation Criteria Solid Tumors mRECIST safety adverse event AEs 1 2 3year OS rate significantly higher cTACE plus TCC group cTACE group 832 v 543 631 v 301 377 v 181 p  0008 significantly longer median OS 290 v 150 months p  0001 Regarding 1 2 3year PFS rates HCC patient cTACE plus TCC group also demonstrated significantly higher rate 663 v 344 358 v 188 318 v 156 p  0014 longer median PFS 160 v 80 months p  0001 compared cTACE group treatmentrelated AEs tolerated patient unresectable HCC TACE combined TCC cocktail well tolerated significantly improved clinical outcomes Trial registration trial registered httpswwwchictrorgcnshowprojhtmlproj27493 ChiCTR1800016335 25th May 2018 named openlabel multicenter randomized prospective clinical trial thalidomide based triple oral regimen lowdose maintenance therapy TACE advanced hepatocellular carcinoma",
        "mesh_terms": [
            "Humans",
            "Carcinoma, Hepatocellular",
            "Liver Neoplasms",
            "Chemoembolization, Therapeutic",
            "Male",
            "Female",
            "Middle Aged",
            "Prospective Studies",
            "Aged",
            "Combined Modality Therapy",
            "Treatment Outcome",
            "Adult"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40702551/",
        "source_type": "Global"
    },
    {
        "pmid": "40700954",
        "title": "Revisiting the association between transportation noise and heart disease reported in the World Health Organization Environmental Noise Guidelines for the European Region: a systematic review and meta-analysis.",
        "abstract": "Whilst link longterm exposure transportation noise cardiovascular disease discussed several decades still uncertainty exact quantitative relationship two systematic review metaanalysis informed recommendation World Health Organization Environmental Noise Guidelines European Region included study published 2015 Since then rapid increase publication epidemiological study exploring risk larger noise exposure range precise exposure assignment Given influential nature Guidelines investigated whether inclusion study published December 2023 change quantitative relationship carried systematic review metaanalysis association transportation noise road rail aircraft heart disease specifically ischaemic heart disease ICD10 I2025 atrial fibrillation ICD10 I48 heart failure ICD10 I50 followed methodology search terms inclusion criteria risk bias evaluation assessment quality evidence systematic review Pooled effect estimate calculated road railway aircraft mixed noise source using random effect models road traffic noise investigated potential source betweenstudy heterogeneity using metaregression also explored potential effect noise exposure assignment precision effect estimates Fiftythree study included systematic review 85  investigated association road 23  rail 30  aircraft noise exposure paper spanned 15 countries majority 87  study investigating population within European countries total 35 study included metaanalyses heart disease incidence 28 mortality five prevalence found positive association longterm exposure road traffic aircraft noise heart disease incidence relative risk RR  102 95  confidence interval CI101 104 RR  103 099 107 per 10 dB increase Lsubdensub respectively longterm road rail aircraft noise exposure heart disease mortality RR  103  101 105 RR  102 102 103 RR  107 101 114 per 10 dB increase Lsubdensub respectively pooled estimate aircraft noise attenuated excluded smallarea study analysis RR  100 099 101 incidence RR  103 098 107 mortality combining source transport noise found similar pooled effect estimate heart disease incidence RR  103 101 104 mortality RR  103 102 105 per 10 dB Lsubdensub increase longterm noise exposure starting point exposure response relationship 32 45 dB Lsubdensub depending source outcome exposure mostexposed façade found suggestive evidence effect estimate could higher study focused older adult study using precise exposure assignment noise calculated residential address floor height although study needed confirm findings epidemiological evidence association transportation noise heart disease increased rapidly since publication Environmental Noise Guidelines 2018 although effect noise railway aircraft remain relatively understudied including newer studies found different exposure response relationship road traffic noise association railway aircraft noise heart disease mortality result implication quantitative health risk assessment inform policy decision making Caution needed applying result population setting outside Europe Future epidemiological study aim use precise exposure assignment calculated residential address rather estimating spatial grid coarse spatial resolution",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40700954/",
        "source_type": "Global"
    },
    {
        "pmid": "40699349",
        "title": "Management of fatigue in children with cancer: a survey of pediatric hematology-oncology professionals' knowledge, attitudes, and practices in the United States and Canada.",
        "abstract": "Children cancer frequently experience fatigue affect quality life yet current management practice remain poorly understood aimed assess health care professionals HCPs knowledge attitudes practice regarding fatigue management pediatric oncology conducted crosssectional webbased survey pediatric hematologyoncology HCPs United States America Canada assess fatigue education management practices barrier fatigue management perspective future clinical trial fatigue Quantitative data analyzed using descriptive statistics chisquare test logistic regression framework approach used analyze qualitative data openended survey response items total 528 HCPs completed survey 49 oncologists 27 nurses 23 nurse practitioners 29 32 HCPs attended educational event fatigue screened patient fatigue primarily verbal assessment outpatient settings respectively Although 91 HCPs emphasized importance assessing fatigue 18 familiar fatigue management guidelines 1 followed them Commonly recommended fatigue intervention included sleep hygiene 91 physical exercise 82 rest 78 Themes improving fatigue management included enhancing education HCPs patients implementing routine fatigue screening disseminating guideline fatigue management resources Barriers effective fatigue management insufficient education lack routine screening limited access fatigue screening tools HCPs 94 supported future clinical trial fatigue management 86 preferred trial test nonpharmacological intervention fatigue management HCPs acknowledge importance assessing fatigue significant gap remain education routine screening guideline implementation Addressing barrier insufficient education limited access resource essential improving fatigue management practices",
        "mesh_terms": [
            "Humans",
            "Cross-Sectional Studies",
            "Canada",
            "Fatigue",
            "Health Knowledge, Attitudes, Practice",
            "Neoplasms",
            "United States",
            "Child",
            "Female",
            "Male",
            "Adult",
            "Quality of Life",
            "Surveys and Questionnaires",
            "Attitude of Health Personnel"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40699349/",
        "source_type": "Global"
    },
    {
        "pmid": "40698693",
        "title": "Unveiling the Healing Potential of Stem Cells: The Promising Role of Secretome Therapy in the Treatment of Pulmonary Degenerative Disorders-A Comprehensive Systematic Review.",
        "abstract": "Stem cellbased therapy emerged promising avenue treating pulmonary degenerative disorder due remarkable capacity selfrenewal differentiation various cell types However concern regarding undesired differentiation tumorigenicity raised question safety efficacy cellbased therapy aim present systematic review study determine therapeutic effectiveness stem cell secretome mitigating three pulmonary degenerative diseases including Acute Lung Injury ALI Idiopathic Pulmonary Fibrosis IPF Bronchopulmonary Dysplasia BPD comprehensive search carried international databases including MEDLINE Scopus Web Science PubMed Embase using related keywords according Preferred Reporting Items Systematic Reviews MetaAnalyses PRISMA2020 guidelines 1541 retrieved studies 136 article included present systematic review therapeutic effect stem cell primarily attributed paracrine secretions specifically bioactive molecule known secretome includes exosomes extracellular vesicles Secretomebased therapy show great promise maximizing healing potential stem cells However several challenge limitation hinder widespread application including scalability issues delivery challenges difficulty controlling dosage lack standardized production protocols novel therapeutic approach complex composition mechanism action variability response body well longterm safety remain unknown pose challenge necessitate investigation welldesigned clinical trials secretome exerts protective therapeutic effect regulating various processes including inflammation oxidative stress cell apoptosis macrophage polarization growth factor signaling pathways immune cell activation TGFβ signaling pathways angiogenesis structural attenuation fibrosis resolution pulmonary functional improvement alveolarization",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40698693/",
        "source_type": "Global"
    },
    {
        "pmid": "40697781",
        "title": "Phenome-wide association of physical activity with morbidity and mortality risk in China: A prospective cohort study.",
        "abstract": "Research highincome country established health benefit physical activity PA evidence low middleincome countries including China PA pattern vary highincome countries remains limited Moreover previous research mainly focused specific diseases failing fully capture health impact PA investigated association PA 425 distinct disease 53 cause death using data 511088 participant aged 3079 year China Kadoorie Biobank Baseline PA assessed using questionnaire 2004 2008 usual PA level estimated using resurvey data 20132014 Cox regression employed estimate association PA outcomes adjusting potential confounders median followup time 12 years 722183 incident event 39320 death recorded across 18 chapter International Classification Diseases 10th Revision ICD10 Total PA significantly inversely associated incidence risk 14 ICD10 chapters specifically 65 disease 19 cause death highest quintile group PA showing 14 lower disease incidence 40 lower allcause mortality compared lowest group diseases 54 highlighted World Health Organization PA guidelines Doseresponse analysis revealed Lshaped association PA types except moderatetovigorous intensity PA showed Ushaped relationship population physical inactivity accounted 128 PArelated deaths finding underscore broad health benefit PA across variety body system significant disease burden due inactivity China highlighting urgent need PA promotion",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40697781/",
        "source_type": "Global"
    },
    {
        "pmid": "40696292",
        "title": "Socioeconomic and sociodemographic differences in the consequences of the COVID-19 pandemic and their impact on self-rated health and mental well-being: results from a cross-sectional study in Germany.",
        "abstract": "Although COVID19 pandemic demonstrably led increase health inequities study analyzed underlying mechanism taking account socioeconomic status sociodemographic difference time Similarly study explored impact COVID19 containment measure inequity living conditions healthrelated risks coping resources study aim address gap exploring complex association socioeconomic sociodemographic factor change life circumstances pandemicrelated experiences selfrated health wellbeing among adult living Germany total 2123 adult women 498 men 502 living Germany participated crosssectional online study ExCoWell July August 2022 survey included question socioeconomic status sociodemographic factors social circumstances resource burdens well health outcomes data analyzed using bivariate multivariable logistic regression analyses result show significant disparity selfrated health mental wellbeing based socioeconomic status sociodemographic differences result mixed woman consistently showing worse health outcome men Immigration status played limited role Although measure contain COVID19 pandemic commonly affected life work condition privileged participants socioeconomically disadvantaged participant experienced higher burden fewer coping resources Logistic regression analysis showed health inequity decreased resource burden considered covering whole period COVID19 pandemic data allow overall assessment critical time well better understanding mechanism underlying health inequities finding suggest important number governmentinduced social change quality potential negatively impact material social livelihood long run improve health equity tailored social security health promotion intervention need systematically integrated pandemic crisis response plans",
        "mesh_terms": [
            "Humans",
            "Germany",
            "Cross-Sectional Studies",
            "COVID-19",
            "Male",
            "Female",
            "Adult",
            "Middle Aged",
            "Mental Health",
            "Health Status Disparities",
            "Socioeconomic Factors",
            "Sociodemographic Factors",
            "Pandemics",
            "Aged",
            "Social Class",
            "Self Report"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40696292/",
        "source_type": "Global"
    },
    {
        "pmid": "40695895",
        "title": "A cross-sectional analysis of remnant cholesterol-diabetes association in US adults.",
        "abstract": "relationship remnant cholesterol diabetes critical issue field health public health Currently relationship remnant cholesterol RC diabetes highly researched trending topic aim study investigate association RC diabetes US individuals secondary objective study explore potential doseresponse relationship exposure RC diabetes study utilized available continuous data National Health Nutrition Examination Survey NHANES 2013 2018 Multivariable logistic regression model used investigate association RC diabetes association RC diabetes assessed using smoothing spline generated generalized additive models Additionally threshold effect analysis relationship RC diabetes conducted Analysis 6875 eligible adult derived initial cohort 7780 exclusion missing diabetescholesterol data revealed significant threshold effect 19 mgdLof remnant cholesterol RC diabetes prevalence Participants RC  19 mgdL exhibited substantially elevated diabetes odds unadjusted OR  180 95 CI 157206 P  0001 fully adjusted model OR  146 95 CI 130164 P  0001 whereas RC ≥ 19 mgdL demonstrated significant association adjusted  099 95 CI 088125 P  096 Quartile analysis confirmed robust dosedependent relationship compared Quartile 1 RC ≤ 12 mgdL reference diabetes odds progressively increased  172 95 CI 137216​for Quartile 2 1318 mgdL  232 95 CI 186291 Quartile 3 1926 mgdL  342 95 CI 277421​for Quartile 4 2780 mgdL significant trend persistence multivariable adjustment P  0001 association remained significant despite substantial demographic variation across RC quartiles including difference age P  0001 sex distribution P  0001 racialethnic composition P  0001 crosssectional analysis observed elevated RC level significantly associated higher prevalence diabetes adult aged 2080 years threshold value 19 mgdL increased association strength finding support RC metabolic marker associated prevalent diabetes threshold value 19 mgdL strengthened association",
        "mesh_terms": [
            "Humans",
            "Male",
            "Female",
            "Cross-Sectional Studies",
            "Middle Aged",
            "Cholesterol",
            "Adult",
            "United States",
            "Diabetes Mellitus",
            "Nutrition Surveys",
            "Triglycerides",
            "Aged",
            "Prevalence",
            "Risk Factors",
            "Lipoproteins"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40695895/",
        "source_type": "Global"
    },
    {
        "pmid": "40695422",
        "title": "What guides regional nodal irradiation in node positive breast cancer following upfront sentinel lymph node biopsy?",
        "abstract": "study aimed evaluate decisionmaking pattern among international expert regarding breast cancer regional node irradiation RNI using objective consensusdriven approach Twentyone international radiation oncology expert invited participate consensusbased evaluation RNI recommendations Participants provided response clinical scenario involving earlystage breast cN0 cancer sentinel lymph node biopsy SNLBpositive finding pN1a without completion axillary lymph node dissection ALND Decisionmaking parameters including patient age tumour characteristics biological risk factor analysed 21 experts 19 completed evaluation Responses included 22 different decisionmaking criterion demonstrated considerable variability decisionmaking even simplifying treatment options Consensus frequently observed high lowrisk cases comprehensive RNI omission RNI recommended respectively However intermediaterisk scenarios clear agreement reached reflecting different clinical consideration assessment risk factors Due many randomised study investigating different risk factor always coincide breast cancer expert rely wide variety criterion recommend RNI pN1sn breast cancer leading heterogeneity decisionmaking work aim raise awareness challenge provoke revision current guideline expertbased recommendations",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40695422/",
        "source_type": "Global"
    },
    {
        "pmid": "40693733",
        "title": "Clinical Practice Consensus Statement 2025: Management of Hyperuricemia and Gout in Adolescents.",
        "abstract": "response increasing global prevalence gout concerning shift towards younger demographic China forefront trend Hyperuricemia central factor pathogenesis gout becoming increasingly common among adolescents particularly males associated various health risks including joint pain CKD metabolic disorders premature death Despite seriousness issue lack specific guideline addressing adolescent hyperuricemia gout management working comprising 26 clinician pediatricians rheumatologists endocrinologists experienced clinical presentation management gout hyperuricemia convened develop consensus systematic literature search conducted PubMed Cochrane Library EMBASE published 1 January 1960 31 May 2024 Two round Delphi survey recommendation conducted among group member via electronic questionnaire Adolescentonset gout characterized pronounced genetic predisposition distinct environmental influences significant number case reporting positive family history issued three consensus statement five recommendation including criteria uratelowering treatment flare therapy principle hyperuricemia gout adolescents consensus statement comprehensively delf critical clinical challenge associated gout hyperuricemia adolescent population emphasizing pressing requirement improved detection management strategy support demographic may underserved healthcare system",
        "mesh_terms": [
            "Humans",
            "Hyperuricemia",
            "Gout",
            "Adolescent",
            "Gout Suppressants",
            "Consensus",
            "Male",
            "Female",
            "Uric Acid",
            "Delphi Technique"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40693733/",
        "source_type": "Global"
    },
    {
        "pmid": "40691827",
        "title": "Exploring oral hygiene practices, nutritional habits and caries risk among children, adolescents and young adults: a multiregional perspective in the post-COVID-19 era.",
        "abstract": "COVID19 pandemic emerged late December 2019 significantly altered dietary oral healthrelated habit lifestyle nearly every age group within global population purpose research explore impact COVID19 pandemic dietary behaviors daily oral hygiene practice caries risk among children adolescents young adult diverse region within Saudi Arabia crosssectional analytical study spanning multiple region Saudi Arabia carried assess effect COVID19 dietary habits oral hygiene practices caries risk across various age group within Saudi population total 655 participant included study providing informed consent Data collection performed using questionnaire divided four sections personal demographic information socioeconomic information oral hygiene practices dietary habits prior COVID19 lockdown notable increase caries experience rate escalated 261 onset COVID19 pandemic 450 pandemic P  0001 finding suggest significant shift dietary practice child adolescent comparing two timeframes Specifically marked rise meal frequency P  0001 snacking pattern P  0001 consumption sugary product like candies chocolates milk coffee P  0001 pandemic Furthermore percentage child adolescent brushing teeth three time day plummeted 478 pandemic mere 43 P  0001 proportion individual using fluoride toothpaste also experienced decline falling 159 pandemic 52 crisis P  0001 study illustrates COVID19 pandemic substantially changed dynamic dental caries oral health resulting increased risk caries worrying decline daily oral hygiene practices Additionally significant drop application topical fluoride via toothpaste finding point critical importance personalized dental care public health crisis alleviate negative effect ensure maintenance oral health",
        "mesh_terms": [
            "Humans",
            "Adolescent",
            "COVID-19",
            "Dental Caries",
            "Oral Hygiene",
            "Cross-Sectional Studies",
            "Child",
            "Saudi Arabia",
            "Male",
            "Female",
            "Young Adult",
            "Feeding Behavior",
            "Risk Factors",
            "SARS-CoV-2",
            "Surveys and Questionnaires"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40691827/",
        "source_type": "Global"
    },
    {
        "pmid": "40691183",
        "title": "C-reactive protein-triglyceride glucose index and heart failure in US adults from NHANES 2001-2010.",
        "abstract": "Creactive proteinCRPtriglyceride glucose index CTI new composite biomarker used assess inflammation insulin resistanceIR severity Heart failure HF pose substantial epidemiological threat increasing incidence mortality worldwide However relationship CTI HF extensively investigated Using crosssectional data National Health Nutrition Examination Survey NHANES 20012010 21974 participant ≥ 20 year included HF diagnosis based selfreported medical history Multivariable logistic regression adjusted demographic lifestyle clinical covariates Smooth curve fitting analyzed doseresponse relationships subgroup analysis explored effect heterogeneity research cohort comprised 21974 individual 631 HF cases 21343 nonHF HF patient exhibited significantly higher CTI level p  0001 positive correlation HF prevalence observed p  0001 Consistent positive association maintained across subgroups significant interaction detected Logistic regression analysis demonstrated adjusted ORs HF per 1unit CTI increase 1492 model 1 unadjusted 1279 model 3 fully adjusted Quartile analysis revealed progressive increase prevalent HF higher CTI levels model 3 confirmed nonlinear doseresponse relationship p  0001 threshold 11657 CTI positively associated presence HF US adults suggesting potential biomarker HF prevention treatment strategies",
        "mesh_terms": [
            "Humans",
            "Heart Failure",
            "Male",
            "Female",
            "Middle Aged",
            "C-Reactive Protein",
            "Nutrition Surveys",
            "United States",
            "Adult",
            "Biomarkers",
            "Cross-Sectional Studies",
            "Blood Glucose",
            "Aged"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40691183/",
        "source_type": "Global"
    },
    {
        "pmid": "40689533",
        "title": "Childhood Acute Post Streptococcal Glomerulonephritis in Far North Queensland.",
        "abstract": "determine recent incidence paediatric Acute Post Streptococcal Glomerulonephritis Far North Queensland associated cooccurring clinical conditions Paediatric inpatient unit Patients admitted Hospital 14 year age meeting diagnostic criterion APSGN January 2015 January 2020 Single centre retrospective observational analysis Data clinical information extracted electronic medical records Case definition specified Northern Territory guideline APSGN APSGN n  61 probable APSGN n  4 found 65 86 identified cases Fiftyfive APSGN case identified Aboriginal andor Torres Strait Islander remaining 10 case identifying ethnic groups Mean annual incidence 014 years 27100 000 person years Aboriginal andor Torres Strait Islander population incidence 104100 000 person years Recurrent skin infection noted majority cases Nineteen case lost follow up these 15 rural regions high incidence childhood APSGN present Far North Queensland First nations child overrepresented add national body data disease highlighting necessity amplified response addressing disease burden group Streptococcus main drivers social disadvantage remoteness need enhanced surveillance monitoring chronic sequela APSGN Opportunities exist amalgamate followup practice across region need enact reporting disease Queensland",
        "mesh_terms": [
            "Humans",
            "Queensland",
            "Streptococcal Infections",
            "Child",
            "Retrospective Studies",
            "Male",
            "Female",
            "Child, Preschool",
            "Incidence",
            "Infant",
            "Glomerulonephritis",
            "Adolescent",
            "Streptococcus pyogenes",
            "Infant, Newborn",
            "Acute Disease"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40689533/",
        "source_type": "Global"
    },
    {
        "pmid": "40685343",
        "title": "Impact of the new Japanese medical specialty system on residents' career choices in general medicine: a nationwide cross-sectional study.",
        "abstract": "General medicine GM formally recognized specialty Japan 2018 address need primary care Understanding factor influencing GM career choice critical recruitment However reforms impact career decisionmaking remains unclear study examined factor influencing GM career choice following introduction new specialty certification identified challenge field secondary analysis national survey data Ministry Health Labour Welfares questionnaire 20182020 clinical training graduate examined posttraining career intention specializing GM focusing factor influencing choice demographics education training contexts Multivariable logistic regression conducted posttraining GM preference dependent variable result expressed adjusted odds ratio aORs 95 confidence interval CIs Among 16674 complete responses 59 229 individual initially interested GM actually pursued posttraining Positive factor included regional quota aOR 310 95 CI 112856 ≤ 1 month GM rotation aOR 339 95 CI 1031114  2 month community medicine CM rotation aOR 1335 95 CI 2407658 desire primary care skill aOR 485 95 CI 2011173 community contribution aspiration aOR 688 95 CI 2751721 influential negative factor perceived ease specialization maintenance aOR 001 95 CI 000012 Among 16445 individual preferred specialties 86 switched GM Extended GM rotation 1≤2 months aOR 354 95 CI 206609 2 months aOR 741 95 CI 4561204 increased likelihood switching Academic interest aOR 036 95 CI 023058 perceived ease maintaining specialization aOR 013 95 CI 003054 negative factors GM rotation may positively influence career choices longer CM rotation potentially increasing interest Establishing clear career path educating resident physician academic characteristic GM remain challenging despite recognition specialty",
        "mesh_terms": [
            "Career Choice",
            "Humans",
            "Cross-Sectional Studies",
            "Japan",
            "Female",
            "Male",
            "Adult",
            "Internship and Residency",
            "General Practice",
            "Surveys and Questionnaires",
            "Specialization",
            "East Asian People"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40685343/",
        "source_type": "Global"
    },
    {
        "pmid": "40684214",
        "title": "Activated TBK1 promotes ACSL1-mediated microglia lipid droplet accumulation and neuroinflammation in Parkinson's disease.",
        "abstract": "Microgliamediated neuroinflammation play crucial role progression Parkinson’s disease PD Dysregulation lipid droplet homeostasis significant factor affecting microglial inflammatory responses mechanism underlying lipid droplet imbalance PD currently unclear Here report subtype microglia characterized high expression longchain acylCoA synthetase 1 ACSL1 singlenucleus RNA sequencing analysis machine learning algorithms linking lipid metabolism PD neuroinflammation result multiple loss gainoffunction experiment indicate ACSL1 localized endoplasmic reticulum ER promotes lipid droplet accumulation exacerbate microglial activation dopaminergic neuron death Mechanistically activation TANKbinding kinase 1 TBK1 lead enrichment ACSL1 endoplasmic reticulum generates acylCoA channelled lipid droplet biogenesis Additionally high expression ACSL1 promotes activation TBK1 Nrdp1mediated K63 ubiquitination TBK1 trigger amplification aforementioned biological effects Moreover NFκB directly bind ACSL1 promoter positively regulates transcription resulting increased ACSL1 expression microglia finding suggest manipulating lipid droplet biogenesis modulating ACSL1 may potential strategy treating neuroinflammation PD patients online version contains supplementary material available 101186s12974025035170",
        "mesh_terms": [],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40684214/",
        "source_type": "Global"
    },
    {
        "pmid": "40684126",
        "title": "Prognostic value of albumin-corrected anion gap in critically ill patients with sepsis-associated liver injury: a retrospective study.",
        "abstract": "Albumincorrected anion gap ACAG closely associated prognosis many critical illnesses However prognostic value ACAG sepsisassociated liver injury SALI poorly understood explored association ACAG patient prognosis individual diagnosed SALI Data patient SALI admitted intensive care unit ICU 2008 2022 retrospectively analyzed ACAG calculated based first measurement anion gap albumin level within 24 h admission optimal cutoff value ACAG established using R statistical software KaplanMeier analysis conducted compare mortality risk two groups multivariable Cox proportional hazard regression model employed examine association ACAG mortality risk SALI patients assess potential doseresponse relationship restricted cubic spline RCS applied Lastly subgroup analysis carried investigate correlation ACAG level prognosis across different patient populations total 443 critically ill patient SALI included lower n  342 higher ACAG n  101 group based ACAG levels statistically significant difference observed two group regarding age sex ethnicity P  012 084 085 respectively However patient higher ACAG group exhibited greater propensity developing respiratory failure rate ICU inhospital 14day 28day 90day mortality significantly elevated higher ACAG group all P  0001 Higher ACAG level significantly associated increased mortality risk multiple time point all P  0001 ACAG level mortality showed significant linear relationship impact ACAG mortality risk remained consistent across subgroup defined age sex hypertension diabetes respiratory failure significant interaction observed all P interaction  005 ACAG serf significant independent predictor mortality risk patient SALI ACAG predicts shortterm mortality risk such ICU mortality longterm mortality risk such 90day mortality ACAG may serve valuable tool prognostic assessment patient SALI broad applicability",
        "mesh_terms": [
            "Humans",
            "Retrospective Studies",
            "Male",
            "Female",
            "Critical Illness",
            "Sepsis",
            "Middle Aged",
            "Prognosis",
            "Aged",
            "Intensive Care Units",
            "Acid-Base Equilibrium",
            "Liver Diseases",
            "Adult",
            "Serum Albumin"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40684126/",
        "source_type": "Global"
    },
    {
        "pmid": "40684121",
        "title": "High altitude might increase risk of incident frailty in older adults: a nationwide longitudinal survey.",
        "abstract": "number resident high altitude high globally yet study conducted association altitude incident frailty evaluated prospective association doseresponse relationship altitude frailty among Chinese older adults conducted prospective cohort study using data China Health Retirement Longitudinal Survey CHARLS 2013 2018 enrolling 4065 participant aged ≥ 60 year baseline Frailty assessed using frailty index FI containing 29 health deficit indicator constructed Cox proportional hazard regression linear mixed model used analyze association altitude frailty Restricted Cubic Spline regression used assess doseresponse relationship them median followup 61 months 1076 265 frailty event documented including 137 322 middle 939 258 low altitude group FI middle altitude group higher low altitude group three wave baseline  2013 wave 1  2015 wave 2  2018 years risk incident frailty increased 24 HR  124 95CI 103148 middle altitude group compared low altitude group FI increased increasing altitude RCS revealed increased risk developing frailty altitude 2000 m Exposure high altitude associated elevated risk incident frailty suggested early intervention highaltitude resident delay frailty",
        "mesh_terms": [
            "Humans",
            "Aged",
            "Altitude",
            "Male",
            "Female",
            "Longitudinal Studies",
            "Frailty",
            "China",
            "Prospective Studies",
            "Middle Aged",
            "Incidence",
            "Risk Factors",
            "Frail Elderly",
            "Aged, 80 and over"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40684121/",
        "source_type": "Global"
    },
    {
        "pmid": "40684084",
        "title": "Abemaciclib in combination with endocrine therapy for the treatment of HR-positive/HER2-negative locally advanced/metastatic breast cancer in the UK: an observational study.",
        "abstract": "Cyclindependent kinase 46 inhibitor combined endocrine therapy standard care first secondline setting hormone receptor positive HR human epidermal growth factor 2 negative HER2 patient advanced  metastatic breast cancer ABCMBC Abemaciclib first authorised United Kingdom UK 2018 via patient access scheme approval routine use study assessed treatment pattern outcome abemaciclib combination endocrine therapy realworld setting observational multicentre retrospective chart review woman UK HR HER2 ABCMBC treated abemaciclib plus endocrine therapy 072021 052022 Formula see text3 months followup data Data summarised using descriptive analyses KaplanMeier method estimated time progression TTP 95 confidence interval CIs One hundred seventyfour adult woman 9 institution included Median patient age abemaciclib initiation 652 years Best tumor response recorded 782 n  136 patients 07 complete response 279 partial response 596 stable disease 118 disease progressed Abemaciclib associated 12month TTP rate 811 first line 682 second line 582 third line median TTP patient received abemaciclib first second third line treatment was reached 277 month 95 CI 117 monthsnot reached 193 month 95 CI 77219 months respectively finding support benefit abemaciclib woman HR HER2 ABCMBC realworld complement data MONARCH 2 3 clinical trials",
        "mesh_terms": [
            "Humans",
            "Female",
            "Aminopyridines",
            "Breast Neoplasms",
            "Benzimidazoles",
            "Middle Aged",
            "Receptor, ErbB-2",
            "United Kingdom",
            "Antineoplastic Combined Chemotherapy Protocols",
            "Retrospective Studies",
            "Aged",
            "Adult",
            "Receptors, Progesterone",
            "Receptors, Estrogen",
            "Aged, 80 and over",
            "Antineoplastic Agents, Hormonal",
            "Neoplasm Metastasis"
        ],
        "source": "https://pubmed.ncbi.nlm.nih.gov/40684084/",
        "source_type": "Global"
    }
]